<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ep-patent-document PUBLIC "-//EPO//EP PATENT DOCUMENT 1.0//EN" "ep-patent-document-v1-0.dtd">
<ep-patent-document id="EP96934530B1" file="96934530.xml" lang="en" country="EP" doc-number="0853676" kind="B1" date-publ="20060621" status="n" dtd-version="ep-patent-document-v1-0">
<SDOBI lang="en"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFI......AL..............................</B001EP><B003EP>*</B003EP><B005EP>J</B005EP><B007EP>DIM360 (Ver 1.5  21 Nov 2005) -  2100000/0</B007EP></eptags></B000><B100><B110>0853676</B110><B120><B121>EUROPEAN PATENT SPECIFICATION</B121></B120><B130>B1</B130><B140><date>20060621</date></B140><B190>EP</B190></B100><B200><B210>96934530.5</B210><B220><date>19961004</date></B220><B240><B241><date>19980409</date></B241><B242><date>20030926</date></B242></B240><B250>en</B250><B251EP>en</B251EP><B260>en</B260></B200><B300><B310>95402241</B310><B320><date>19951006</date></B320><B330><ctry>EP</ctry></B330><B310>95203328</B310><B320><date>19951208</date></B320><B330><ctry>EP</ctry></B330></B300><B400><B405><date>20060621</date><bnum>200625</bnum></B405><B430><date>19980722</date><bnum>199830</bnum></B430><B450><date>20060621</date><bnum>200625</bnum></B450><B452EP><date>20060127</date></B452EP></B400><B500><B510EP><classification-ipcr sequence="1"><text>C12N  15/82        20060101AFI19970616BHEP        </text></classification-ipcr><classification-ipcr sequence="2"><text>C12N  15/56        20060101ALI19970616BHEP        </text></classification-ipcr><classification-ipcr sequence="3"><text>A01H   5/00        20060101ALI19970616BHEP        </text></classification-ipcr></B510EP><B540><B541>de</B541><B542>SAMENSTRENUNG RESISTENZ</B542><B541>en</B541><B542>SEED SHATTERING</B542><B541>fr</B541><B542>ECLATEMENT DES GRAINES</B542></B540><B560><B561><text>EP-A- 0 271 988</text></B561><B561><text>WO-A-93/02197</text></B561><B561><text>WO-A-94/01572</text></B561><B561><text>WO-A-94/23043</text></B561><B561><text>WO-A-96/30529</text></B561><B562><text>ANNUAL MEETING OF THE AMERICAN SOCIETY OF PLANT PHYSIOLOGISTS, CHARLOTTE, NORTH CAROLINA, USA, JULY 29-AUGUST 2, 1995. PLANT PHYSIOLOGY (ROCKVILLE) 108 (2 SUPPL.). 1995. 75., XP002002155 PETERSEN M., ET AL.: "An endo-polygalacturonase isoform potentially involved in pod dehiscence in oilseed rape ."</text></B562><B562><text> PLANT MOL. BIOL. 11:651-662(1988)., XP002002156 BIRD C.R., ET AL.: "The tomato polygalacturonase gene and ripening-specific expression in transgenic plants"</text></B562><B562><text>PLANT MOLECULAR BIOLOGY 31 (3). 1996. 517-527, XP002025026 PETERSEN M ET AL: "Isolation and characterisation of a pod dehiscence zone-specific polygalacturonase from Brassica napus."</text></B562><B562><text>EMBL SEQUENCE DATABASE. REL.48. ACCESSION NO. X98373. 12-JUN-1996., XP002025254 SANDER L.: "B.napus gene encoding endo-polygalacturonase"</text></B562><B562><text>ANNUAL MEETING OF THE AMERICAN SOCIETY OF PLANT PHYSIOLOGISTS,PORTLAND, OREGON, USA, JULY 30-AUGUST 3, 1994. PLANT PHYSIOLOGY (ROCKVILLE) 105 (1 SUPPL.). 1994. 56., XP002002157 BORKHARDT B., ET AL.: " Changes in cell structure and expression of genes encoding polysaccharide hydrolases during pod development in oilseed rape (Brassica napus L.)."</text></B562><B562><text>GENETICAL RESEARCH, vol. 56, no. 1, 1 August 1990, page 1/2 XP000574919 PRAKASH S ET AL: "RECONSTRUCTION OF ALLOPOLYPLOID BRASSICAS THROUGH NONHOMOLOGOUS RECOMBINATION: INTROGRESSION OF RESISTANCE TO POD SHATTER IN BRASSICA NAPUS"</text></B562><B562><text>JOURNAL OF EXPERIMENTAL BOTANY, vol. 47, no. 294, 1 January 1996, pages 111-115, XP000570275 JENKINS E S ET AL: "CHARACTERIZATON OF AN MRNA ENCODING A POLYGALACTURONASE EXPRESSED DURING POD DEVELOPMENT IN OILSEED RAPE (BRASSICA NAPUS L.)" &amp; PHD THESIS UNIVERSITY OF NOTTINGHAM, 1993, COUPE, S. A.: "Changes in gene expression during pod development in oilseed rape (Brassica napus L.)"</text></B562></B560></B500><B700><B720><B721><snm>ULVSKOV, Peter</snm><adr><str>Hostvej 10</str><city>DK-2920 Charlottenlund</city><ctry>DK</ctry></adr></B721><B721><snm>CHILD, Robin</snm><adr><str>20 Fosse Close,
Nailsea</str><city>Bristol BS19 2BE</city><ctry>GB</ctry></adr></B721><B721><snm>VAN ONCKELEN, Henri</snm><adr><str>J. Verbovenlei 75</str><city>B-2100 Deurne</city><ctry>BE</ctry></adr></B721><B721><snm>PRINSEN, Els</snm><adr><str>Timmerdonckstraat 5/11</str><city>B-2650 Edegem</city><ctry>BE</ctry></adr></B721><B721><snm>BORKHARDT, Bernhard</snm><adr><str>Lindegardsvej 27</str><city>DK-3520 Farum</city><ctry>DK</ctry></adr></B721><B721><snm>SANDER, Lilli</snm><adr><str>Vennemindevej 59</str><city>DK-2100 Copenhagen</city><ctry>DK</ctry></adr></B721><B721><snm>PETERSEN, Morten</snm><adr><str>Arkonagade 2</str><city>DK-1726 Copenhagen V</city><ctry>DK</ctry></adr></B721><B721><snm>BUNDGARD POULSEN, Gert</snm><adr><str>Madvigs Aile 5</str><city>DK-1829 Copenhagen V</city><ctry>DK</ctry></adr></B721><B721><snm>BOTTERMAN, Johan</snm><adr><str>Het Wijngaardeke 5</str><city>B-9840 Zevergem</city><ctry>BE</ctry></adr></B721></B720><B730><B731><snm>Bayer BioScience N.V.</snm><iid>04211101</iid><irf>JDS.vdh/06-198</irf><adr><str>Technologiepark 38</str><city>9052 Gent</city><ctry>BE</ctry></adr></B731></B730><B740><B741><snm>Desomer, Jan G.M.</snm><iid>00134811</iid><adr><str>Bayer BioScience N.V. 
BioScience IP Department 
Technologiepark 38</str><city>9052 Gent</city><ctry>BE</ctry></adr></B741></B740></B700><B800><B840><ctry>AT</ctry><ctry>BE</ctry><ctry>CH</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>IE</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LU</ctry><ctry>MC</ctry><ctry>NL</ctry><ctry>PT</ctry><ctry>SE</ctry></B840><B844EP><B845EP><ctry>AL</ctry><date>19980406</date></B845EP><B845EP><ctry>LT</ctry><date>19980406</date></B845EP><B845EP><ctry>LV</ctry><date>19980406</date></B845EP><B845EP><ctry>SI</ctry><date>19980404</date></B845EP></B844EP><B860><B861><dnum><anum>EP1996004313</anum></dnum><date>19961004</date></B861><B862>en</B862></B860><B870><B871><dnum><pnum>WO1997013865</pnum></dnum><date>19970417</date><bnum>199717</bnum></B871></B870></B800></SDOBI><!-- EPO <DP n="1"> -->
<description id="desc" lang="en">
<p id="p0001" num="0001">The present invention relates to pod dehiscence zone-selective chimeric genes and their use for modifying pod dehiscence properties in plants, more particularly pod dehiscence properties in <i>Brassica napus.</i></p>
<heading id="h0001"><b><u style="single">BACKGROUND OF THE INVENTION</u></b></heading>
<p id="p0002" num="0002">Loss of yield due to seed shedding by mature fruits or pods, also called pod dehiscence or pod shatter, as well as concomitant increase in volunteer growth in the subsequent crop year, are a universal problem with crops that develop dry dehiscent fruits. An economically important crop to which these adverse properties specifically apply is oilseed rape: up to 50% of the potential yield may be lost under adverse weather conditions.</p>
<p id="p0003" num="0003">Dry dehiscent fruits, also commonly called pods, may develop from a single carpel (such as the legume in many <i>Fabaceae</i>) or from more than one carpel (such as the silique in many <i>Brassicaceae</i>). In case of the silique, the pod consists of two carpels joined margin to margin. The suture between the margins forms a thick rib, called replum. As pod maturity approaches, the two valves separate progressively from the replum, eventually resulting in the shattering of the seeds that were attached to the replum.</p>
<p id="p0004" num="0004">Ultrastructural investigation have demonstrated that pod shatter is associated with the precise degradation of cell wall material at the site of pod valve separation (i.e., the suture). The degradation of the cell wall and loss of cellular cohesion prior to dehiscence is predominantly attributed to solubilization of the middle lamella of the cell wall. This middle lamella is found between primary cell walls and is the cement that holds the individual cells together to form a tissue. Cell separation is preceded by an ethylene climacteric, which temporally correlates with a tissue-specific increase in the activity of the hydrolytic enzyme<!-- EPO <DP n="2"> --> cellulase (beta-1,4-glucanase) and this occurs specifically in a layer of cells along the suture, which is called the dehiscence zone. In contrast, the activity of the cell wall degrading enzyme polygalacturonase exhibits no correlation either temporally or spatially with pod dehiscence [Meakin and Roberts (1990), <i>J. Exp. Bot</i>. <b>41</b>; 1003]. Pod dehiscence at an early stage of development is characteristic of infestation by the pod midge <i>Dasineura brassicae.</i> A localized enhancement of both polygalacturonase and cellulase activity has been observed. However, regulation of midge-induced and maturation-associated shatter was found to be different [Meakin and Roberts (1991), <i>Annals of Botany</i> <b>67</b>: 193].</p>
<p id="p0005" num="0005">At first sight, the process of pod dehiscence shares a number of features with abscission wherein plants shed organs, such as leaves, flowers and fruits. It has been observed that ethylene induces or accelerates abscission, whereas auxin inhibits or delays abscission. A decisive step in abscission is the highly coordinated expression, synthesis and secretion of cell wall hydrolytic enzymes in a discrete layer of cells, called the abscission zone. Cellulases (beta-1,4-glucanases) constitute one class of such cell wall hydrolases. Cellulase activity has been identified in various tissues including leaf abscission zones, fruit abscission zones, ripening fruit, senescent cotyledons and styles and anthers [Kemmerer and Tucker (1994), <i>Plant Physiol.</i> <b>104</b>: 557 and references therein]. A second class of hydrolases involved in abscission of mainly fruits are polygalacturonases of which distinctive isoforms have been identified [Bonghi et al. (1992), <i>Plant Mol. Biol.</i> <b>20</b>: 839; Taylor et al. (1990) <i>Planta</i> <b>183:</b> 133].</p>
<p id="p0006" num="0006">Kadkol et al. [(1986), <i>Aust. J. Biol.</i> <b>34:</b> 79] reported increased resistance towards shattering in a single, Australian accession of rape. Variation in pod maturation has further been observed in mutants of rape stemming from irradiated seeds [Luczkiewicz (1987), <i>Proc. 7th Int. Rapeseed Congress</i> <b>2</b>: 463]. It can however be concluded that traditional methods for breeding have been unsuccessful in introducing shatter resistance into rape cultivars, without interference in other desirable traits such as early flowering, maturity and blackleg resistance [Prakash and Chopra (1990), <i>Genetical Research</i> <b>56</b>: 1].<!-- EPO <DP n="3"> --></p>
<p id="p0007" num="0007">Despite its economic impact very little is known concerning the molecular events and changes in gene expression that occur during oilseed pod dehiscence. At present, two pod-specific mRNAs whose expression is spatially and temporally correlated with pod development have been described. However, the function of the encoded proteins is unknown. [Coupe <i>et al.</i> (1993), <i>Plant Mol. Biol.</i> <b>23:</b> 1223; Coupe <i>et al.</i> (1994), <i>Plant Mol. Biol.</i> <b>24:</b> 223]. PCT publication WO94/23043 in general terms describes an approach for regulating plant abscission and dehiscence.</p>
<p id="p0008" num="0008">WO 96/30529 describes a nucleic acid sequence coding for a polygalacturonase of <i>Brassica napus.</i></p>
<p id="p0009" num="0009">Petersen <i>et al.</i> (1995, Plant Physiology <b>108</b> (2 suppl.): 75; abstract 342) indicates that an endo-polygalacturonase isoform is potentially involved in pod dehiscence in oilseed rape and mentions the potential application of the corresponding gene for preparing a non-shattering transgenic rape.</p>
<p id="p0010" num="0010">Accordingly, it is an object of the present invention to provide alternative pod dehiscence zone-selective genes in plants.</p>
<p id="p0011" num="0011">These and other objects are achieved by the present invention, as evidenced by the summary of the invention, description of the preferred embodiments and claims.</p>
<heading id="h0002"><b><u style="single">SUMMARY OF THE INVENTION</u></b></heading>
<p id="p0012" num="0012">The present invention provides DNA comprising the nucleotide sequence of SEQ ID No 13 between positions 1,839 and 2,328 and pod dehiscence zone("DZ")-selective promoters comprising said DNA.</p>
<p id="p0013" num="0013">In another aspect, the present invention also provides a pod DZ-selective chimeric gene comprising the following operably linked DNA fragments:
<ul id="ul0001" list-style="none" compact="compact">
<li>a) a transcribed DNA region encoding an RNA capable of inhibiting or reducing the expression of an endogenous gene of the plant encoding a<!-- EPO <DP n="4"> --> cell wall hydrolase selectively expressed in cells of the pod DZ, said cell wall hydrolase comprising the amino acid sequence of the protein encoded by the nucleotide sequence of SEQ ID No 1 between the nucleotide at position 95 and the nucleotide at position 1393; and</li>
<li>b) a plant expressible promoter which directs expression of said transcribed DNA region at least in cells of said pod DZ.</li>
</ul></p>
<p id="p0014" num="0014">In yet another aspect, the present invention provides a pod DZ-selective chimeric gene comprising the following operably linked DNA fragments:
<ul id="ul0002" list-style="none" compact="compact">
<li>a) a transcribed DNA region encoding a protein or polypeptide, which when produced in said pod DZ cells, kills or disables them or interferes with their normal metabolism, physiology or development, selected from the group consisting of:
<ol id="ol0001" compact="compact" ol-style="">
<li>(1) a ribonuclease,</li>
<li>(2) a cytotoxin,</li>
<li>(3) tryptophan monooxygenase, indole-3-acetamide hydrolase, amidohydrolase,</li>
<li>(4) the product of the <i>rolB</i> gene, and</li>
<li>(5) a mutant ETR1 protein, and</li>
</ol></li>
<li>b) a pod DZ-selective promoter comprising the nucleotide sequence of SEQ ID No 13 between positions 1,839 and 2,328.</li>
</ul></p>
<p id="p0015" num="0015">In another aspect, the present invention provides plants comprising the pod DZ-selective chimeric genes as described above, wherein said plants are characterized by delayed pod dehiscence properties, when compared to plants not containing said pod dehiscence zone-selective chimeric genes.</p>
<p id="p0016" num="0016">The present invention also provides plant cells and plant cell cultures transformed with the pod DZ-selective chimeric genes as described above.</p>
<p id="p0017" num="0017">The present invention further provides seed of a plant containing the pod DZ-selective chimeric genes as described above, said seed comprising said pod DZ-selective chimeric genes.<!-- EPO <DP n="5"> --></p>
<p id="p0018" num="0018">In yet another aspect, the present invention provides a method for producing a plant with delayed pod dehiscence properties, which comprises the steps of
<ul id="ul0003" list-style="none" compact="compact">
<li>a) transforming the nuclear genome of a cell of a plant with the pod DZ-selective chimeric genes as described above; and</li>
<li>b) regenerating a transformed plant from said transformed cell.</li>
</ul></p>
<heading id="h0003"><b><u style="single">DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS OF THE PRESENT INVENTION</u></b></heading>
<p id="p0019" num="0019">As used herein, the term "dehiscence" refers to the process wherein a plant organ or structure, such as an anther or fruit, opens at maturity along a certain line or in a definite direction, resulting in the shedding of the content of said organ or structure. In some of its aspects the process of dehiscence is reminiscent of the process of abscission, wherein a part or organ, such as a leaf, flower or fruit, is separated from the rest of the plant.</p>
<p id="p0020" num="0020">As used herein, the term "pod" means a dry dehiscent fruit that consists of one, two or more carpels. In oilseed rape the pod is a bivalve silique, wherein the valves are delineated by longitudinal dorsal and ventral sutures, which comprise the dehiscence zones.</p>
<p id="p0021" num="0021">As used herein, the term "pod dehiscence" means the process wherein a fruit, particularly a pod, splits open along a discrete layer of cells, eventually resulting in the separation of the valves and subsequent shedding of the seeds contained within the fruit, particularly the pod. Pod dehiscence occurs in a large variety of plants that develop dry fruits, such as in most genera of the Cruciferae.</p>
<p id="p0022" num="0022">The term "dehiscence zone" (DZ) in its most general sense includes the tissues in the zone along which a plant organ or structure splits open during the process of dehiscence. Macroscopically the DZ can usually be recognized by the presence of a clear suture in the organ. In the strict sense the DZ may comprise a region of only 1-3 parenchymatous cells wide. In a pod, this region usually comprises densely packed cells and is adjacent to the periphery of vascular tissue of the replum separating it from the valve edges. For the purpose of this<!-- EPO <DP n="6"> --> invention the pod DZ may also include the cell layers surrounding this region. The pod DZ extends from the locule of the pod to the epidermal suture.</p>
<p id="p0023" num="0023">As used herein, the term "promoter" denotes any DNA which is recognized and bound (directly or indirectly) by a DNA-dependent RNA-polymerase during initiation of transcription. A promoter includes the transcription initiation site, and binding sites for transcription initiation factors and RNA polymerase, and can comprise various other sites (e.g., enhancers), at which gene regulatory proteins may bind.</p>
<p id="p0024" num="0024">As used herein, the term "plant-expressible promoter" means a promoter which is capable of driving transcription in a plant cell. This includes any promoter of plant origin, but also any promoter of non-plant origin which is capable of directing transcription in a plant cell, i.e., certain promoters of viral or bacterial origin such as the CaMV 35S or the T-DNA promoters.</p>
<p id="p0025" num="0025">The term "regulatory region", as used herein, means any DNA, that is involved in driving transcription and controlling (i.e., regulating) the timing and level of transcription of a given DNA sequence, such as a DNA coding for a protein or polypeptide. For example, a 5' regulatory region (or promoter region) is a DNA sequence located upstream (i.e., 5') of a coding sequence and which comprises the promoter and the 5'-untranslated leader sequence. A 3' regulatory region is a DNA sequence located downstream (i.e., 3') of the coding sequence and which comprises suitable transcription termination (and/or regulation) signals, including one or more polyadenylation signals.</p>
<p id="p0026" num="0026">As used herein, the term "cell wall hydrolase" means an enzyme that is involved in the degradation of cell wall material, e.g., during the process of dehiscence. Examples of such enzymes include, but are not limited to, polygalacturonase, cellulase (beta-1,4-glucanase), beta-galactosidase, proteases hydrolyzing cell wall proteins, and the like.</p>
<p id="p0027" num="0027">The term "gene" means any DNA fragment comprising a DNA region (the "transcribed DNA region") that is transcribed into a RNA molecule (e.g., a mRNA)<!-- EPO <DP n="7"> --> in a cell under control of suitable regulatory regions, e.g., a plant expressible promoter. A gene may thus comprise several operably linked DNA fragments such as a promoter, a 5' untranslated leader sequence, a coding region, and a 3' untranslated region comprising a polyadenylation site. An endogenous plant gene is a gene which is naturally found in a plant species. A chimeric gene is any gene which is not normally found in a plant species or, alternatively, any gene in which the promoter is not associated in nature with part or all of the transcribed DNA region or with at least one other regulatory regions of the gene.</p>
<p id="p0028" num="0028">The term "expression of a gene" refers to the process wherein a DNA region under control of regulatory regions, particularly the promoter, is transcribed into an RNA which is biologically active i.e., which is either capable of interaction with another nucleic acid or which is capable, of being translated into a biologically active polypeptide or protein. A gene is said to encode an RNA when the end product of the expression of the gene is biologically active RNA, such as an antisense RNA or a ribozyme. A gene is said to encode a protein when the end product of the expression of the gene is a biologically active protein or polypeptide.</p>
<p id="p0029" num="0029">The phenotypic effect of expression of a gene refers to the biochemical, physiological and/or developmental effects of the production of the RNA or protein, encoded by the gene, on the plant cells (or plants) in which it is produced. Phenotypic effects of gene expression may be reduced or prevented by reducing or preventing the production of the encoded RNA or protein, or by otherwise interfering with the biological activity of such RNA or protein.</p>
<p id="p0030" num="0030">As defined herein, whenever it is stated in the specification that a " cDNA of such mRNA comprises the nucleotide sequence of SEQ ID No X" the RNA thus has the same nucleotide sequence as represented in SEQ ID No. X except that the U-residues (in the RNA sequence) are replaced by T-residues (in the DNA sequence).</p>
<p id="p0031" num="0031">Pod DZ-selective cDNAs and their corresponding plant genomic DNA fragments are identified as follows:<!-- EPO <DP n="8"> -->
<ol id="ol0002" ol-style="">
<li>1) a cDNA library is constructed starting from mRNA isolated from pod DZ tissue and the cDNA library is subjected to differential screening in order to identify an mRNA which is selectively present in tissues of the pod DZ when compared to other plant tissues including but not limited to: pod walls, seeds, replum, leaves, stems, roots, reproductive organs, and the like. Alternatively, the cDNA library is screened with oligonucleotides, that are deduced from a determined amino acid sequence of an isolated protein, such as, for example, a cell wall hydrolase, that is identified to be selectively present in the pod DZ. Furthermore, it is possible to use the same oligonucleotides in a nested-PCR approach and to use the amplified fragment(s) as a probe to screen the library. The pod DZ-selective cDNA library can be constructed from a pool of mRNAs, isolated at different stages of pod DZ development;</li>
<li>2) a cDNA, encoding the pod DZ-selective mRNA or protein, is isolated and characterized;</li>
<li>3) this cDNA is used as a probe to identify and isolate the region in the plant genome, comprising the nucleotide sequence encoding the pod DZ-selective mRNA or protein. Alternatively, the genomic DNA can be isolated utilizing inverse PCR using oligonucleotides deduced from the cDNA sequence; and</li>
<li>4) optionally, RNA probes corresponding to the cDNAs are constructed and used in conventional RNA-RNA in-situ hybridization analysis [see e.g., De Block et al. (1993). <i>Anal. Biochem.</i> <b>215</b>: 86] of different plant tissues, including the pod DZ to confirm the selective presence of the mRNA produced by the presumed pod DZ-selective endogenous plant gene in the pod DZ.</li>
</ol></p>
<p id="p0032" num="0032">The term "pod dehiscence zone-selective", with respect to the expression of a DNA in accordance with this invention, refers to, for practical purposes, the highly<!-- EPO <DP n="9"> --> specific, preferably exclusive, expression of a DNA in cells of a pod DZ.</p>
<p id="p0033" num="0033">Thus a pod DZ-selective gene is an endogenous gene of a plant that is selectively expressed in the cells of the pod dehiscence zone of the plant. Any plant which possesses a pod DZ may be used for the isolation of pod DZ-selective genes. Suitable plants for the isolation of pod DZ-selective genes are plants of the family Cruciferae including but not limited to <i>Arabidopsis thaliana, Brassica campestris, Brassica juncea,</i> and especially <i>Brassica napus</i>; plants of the family Leguminosae including but not limited to <i>Glycine max, Phaseolus vulgaris</i> and the like. The mRNA (or the cDNA obtained thereof) transcribed from such a gene is a pod DZ-selective mRNA (or cDNA). A promoter that drives and controls the transcription of such a mRNA is referred to as a pod DZ-selective promoter. A pod DZ-selective promoter can for instance be used to express a cytotoxic gene (e.g., a bamase gene) in a plant so that normal growth and development, and agronomical performance (as measured for instance by seed yield) of the plant is not negatively affected by expression of the cytotoxic gene in cells other than the pod DZ cells.</p>
<p id="p0034" num="0034">Once the pod DZ-selective gene (i.e., the genomic DNA fragment, encoding the pod DZ-selective mRNA from which the pod DZ-selective cDNA can be prepared) is obtained, the promoter region containing the pod DZ-selective promoter is determined as the region upstream (i.e., located 5' of) from the codon coding for the first amino acid of the protein encoded by the mRNA. It is preferred that such promoter region is at least about 400 to 500 bp, preferably at least about 1000 bp, particularly at least about 1500 to 2000 bp, upstream of the start codon. For convenience, it is preferred that such promoter region does not extend more than about 3000 to 5000 bp upstream of the start codon. The actual pod DZ-selective promoter is the region of the genomic DNA upstream (i.e., 5') of the region encoding the pod DZ-selective mRNA. A chimeric gene comprising a pod DZ-selective promoter operably linked to the coding region of the <u style="single">gus</u> gene [Jefferson et al. (1986), <i>Proc. Natl. Acad. Sci. USA</i> <b>83</b>: 8447] will selectively produce, in transgenic plants, detectable beta-glucuronidase activity (encoded by the <u style="single">gus</u><!-- EPO <DP n="10"> --> gene) in the cells of the pod DZ as assayed by conventional <i>in-situ</i> histochemical techniques [De Block and Debrouwer (1992), <i>The Plant Journal</i> <b>2</b>:261; De Block and Debrouwer (1993), <i>Planta</i> <b>189</b>: 218].</p>
<p id="p0035" num="0035">DZ-selective genes from which pod DZ-selective promoters can be obtained, are genes, preferably <i>Brassica napus</i> genes, that encode a pod DZ-selective mRNA from which a cDNA can be prepared that contains the sequence corresponding to the sequence of oligonucleotide PG1 (SEQ ID No 2) between nucleotide positions 11 and 27 and/or the sequence of oligonucleotide PG3 (SEQ ID No 4) between nucleotide positions 11 and 27(i.e., starting at position 11 and ending at position 27); and/or contains the sequence complimentary to the oligonucleotide PG2 (SEQ ID No 3) between nucleotide positions 11 and 25 and/or the sequence of the oligonucleotide PG5 (SEQ 10 No 5) between nucleotide positions 11 and 27. Such pod DZ-selective eDNA contains aforementioned sequences of oligonucleotides PG1 and PG3 and PG2 and PG5. or encodes a protein encoded by the region of SEQ ID No 1 between nucleotide positions 95 and 1,393.</p>
<p id="p0036" num="0036">A pod DZ-selective gene is the <i>Brassica napus</i> gene that encodes a pod DZ-selective mRNA from which a cDNA can be prepared that contains the sequence of SEQ ID No 1 at least between nucleotides 10 and 1600. Another pod DZ-selective gene is the <i>Brassica napus</i> gene, that encode a pod DZ-selective mRNA from which a cDNA can be prepared that contains the sequence of SEQ ID No 10.</p>
<p id="p0037" num="0037">A preferred promoter of the present invention is the promoter contained in the 5' regulatory region of a genomic clone corresponding to the cDNA of SEQ ID No 1, [i.e.], the 5' regulatory region with the sequence of SEQ ID No 13 starting at position 1 and ending at position 2,328. A more preferred promoter region is the DNA fragment comprising the sequence of SEQ ID No 13 starting anywhere between the unique <i>Sph</i>I site (positions 246-251) and the <i>Hind</i>II site (positions 1,836-1,841), particularly between the <i>Sph</i>I site and the <i>Bam</i>HI site (positions 1,051-1,056), and ending at nucleotide position 2,328 (just before the ATG translation start codon). Such a promoter region comprises the pod DZ-selective<!-- EPO <DP n="11"> --> promoter of the subject invention and the 5' untranslated leader region and is used for the construction of pod DZ-selective chimeric genes. In this regard a more preferred promoter region is the DNA fragment (hereinafter referred to as "PDZ") with the sequence of SEQ ID No 13 between positions 251 (the <i>Sph</i>I site) and 2,328.</p>
<p id="p0038" num="0038">However, smaller DNA fragments can be used as promoter regions in this invention and it is assumed that any fragment of the DNA of SEQ ID No 13 which comprises at least the about 490 basepairs, more preferably at least about 661 basepairs and most preferably about 1326 basepairs, upstream from the translation inititation codon can be used. Particularly preferred smaller fragments to be used as promoter region have a DNA sequence comprising the sequence of SEQ ID No 13 between the nucleotides 1002 and 2328.</p>
<p id="p0039" num="0039">It is assumed that the pod DZ-specificity of the promoter of the 5' regulatory region of SEQ ID No 13 can be considerably improved by inclusion of the nucleotide sequence of SEQ ID No 13 between nucleotides 1002 and 1674.</p>
<p id="p0040" num="0040">Alternatively, artificial promoters can be constructed which contain those internal portions of the promoter of the 5' regulatory region of SEQ ID No 13 that determine the pod DZ-selectivity of this promoter. These artifical promoters can contain a "core promoter" or "TATA box region" of another promoter capable of expression in plants, such as a CaMV 35S "TATA box region" as described in WO 93/19188. Suitable promoter fragments or artificial promoters can be identified, for example, by their approriate fusion to a reporter gene (such as the <u style="single">gus</u> gene) and the detection of the expression of the reporter gene in the appropriate tissue(s) and at the appropriate developmental stage. It is known that such smaller promoters and/or artificial promoters comprising those internal portions of the 5' regulatory region of SEQ ID No. 13 that determine the pod DZ selectivity can provide better selectivity of transcription in pod DZ-specific cells and/or enhanced levels of transcription of the transcribed regions of the pod DZ-selective chimeric genes of the invention.<!-- EPO <DP n="12"> --></p>
<p id="p0041" num="0041">Besides the actual promoter, the 5' regulatory region of the pod DZ-selective gene also comprises a DNA fragment encoding a 5' untranslated leader (5'UTL) sequence of an RNA located between the transcription start site and the translation start site. It is assumed that the 5' transcription start site is located between position 2,219 and 2,227 (in SEQ ID No 13), resulting in a 5'UTL of about 102 to 110 nucleotides in length. It is also assumed that this region can be replaced by another 5'UTL, such as the 5'UTL of another plant-expressible gene, without substantially affecting the specificity of the promoter.</p>
<p id="p0042" num="0042">Other useful pod DZ-selective genes or cDNAs are those isolated from other sources, e.g., from other cultivars of <i>B. napus</i> or even from other plant species, for instance by using the cDNA of SEQ ID No1 (or SEQ ID No 10) as a probe to screen genomic libraries under high stringency hybridization conditions using conventional methods as described in <i>Nucleic Acid Hybridization: A Practical Approach</i> (1985), IRL Press Ltd UK (Eds. B.D. Hames and S.J. Higgins). A useful gene is thus any gene characterized by encoding a mRNA from which a cDNA variant can be prepared that contains a coding region with a nucleotide sequence that is essentially similar to that of the coding region of the cDNA clone of SEQ ID No 1, and coding for a protein with polygalacturonase activity. Also promoter regions and promoters can be identified, for example, using such cDNA variants, which are essentially similar to a promoter region or promoter with a sequence as contained in SEQ ID No 13.</p>
<p id="p0043" num="0043">With regard to nucleotide sequences (DNA or RNA), such as sequences of cDNAs or of regulatory regions of a gene, "essentially similar" means that when two sequences are aligned, the percent sequence identity -i.e., the number of positions with identical nucleotides divided by the number of nucleotides in the shorter of the two sequences- is higher than 80%, preferably higher than 90%, especially with regard to regulatory regions. The alignment of the two nucleotide sequences is performed by the Wilbur and Lipmann algorithm [Wilbur and Upmann (1983), <i>Proc. Nat. Acad. Sci. U.S.A.</i> <b>80</b>: 726] using a window-size of 20 nucleotides, a word length of 4 nucleotides, and a gap penalty of 4.<!-- EPO <DP n="13"> --></p>
<p id="p0044" num="0044">Two essentially similar cDNA variants will typically encode proteins that are essentially similar to each other. For example, a variant of the cDNA of SEQ ID No 1 will typically encode a protein with an amino acid sequence which is essentially similar to the amino acid sequence of the protein encoded by the cDNA of SEQ ID No 1. With regard to "amino acid sequences", essentially similar means that when the two relevant sequences are aligned, the percent sequence identity -i.e., the number of positions with identical amino acid residues divided by the number of residues in the shorter of the two sequences- is higher than 80%, preferably higher than 90%. The alignment of the two amino acid sequences is performed by the Wilbur and Lipmann algorithm [Wilbur and Lipmann (1983), <i>Proc. Nat. Acad. Sci. U.S.A.</i> <b>80</b>: 726] Using a window-size of 20 amino acids, a word length of 2 amino acids, and a gap penalty of 4. Computer-assisted analysis and interpretation of sequence data, including sequence alignment as described above, can be conveniently performed using the programs of the Intelligenetics<sup>™</sup> Suite (Intelligenetics Inc., CA).</p>
<p id="p0045" num="0045">The pod DZ-selective CDNAs and genomic DNAs, as well as the regulatory regions obtained from the genomic DNAs are used to modify the dehiscence properties in plants, particularly pod dehiscence properties in <i>Brassica napus.</i></p>
<p id="p0046" num="0046">Thus, in accordance with this invention, a recombinant DNA is provided which comprises at least one pod DZ-selective chimeric gene comprising a pod dehiscence zone-selective promoter comprising the nucleotide sequence of SEQ ID No 13 between positions 1,839 and 2,328 and/or a transcribed DNA region encoding an RNA capable of inhibiting or reducing the expression of an endogenous plant gene encoding a cell wall hydrolase selectively expressed in cells of the pod dehiscence zone, said cell wall hydrolase comprising the amino acid sequence of the protein encoded by the nucleotide sequence of SEQ ID No 1 between the nucleotide at position 95 and the nucleotide at position 1393.</p>
<p id="p0047" num="0047">Expression of a pod DZ-selective chimeric gene in a transgenic plant will have phenotypic effects only in the cells of the pod DZ. Thus, expression of a pod DZ-selective gene may selectively prevent, suppress, inhibit or reduce the<!-- EPO <DP n="14"> --> phenotypic effects of expression of endogenous plant genes in a pod DZ, may selectively kill or disable cells of the pod dehiscence zone, or may interfere with the normal metabolism of pod DZ cells, resulting in the delay or prevention of pod dehiscence. For the purpose of this<!-- EPO <DP n="15"> --> invention, a pod DZ cell is killed or disabled if either all biochemical and/or physiological processes of the cell are stopped or, alternatively, if the biochemical and/or physiological processes of the cell are changed to effectively reduce the extracellular production of at least one enzyme involved in the degradation of plant cell walls, particularly a pectin degrading enzyme such as a polygalacturonase, preferably by at least 30%, particularly by at least 75%, more particularly by at least 90%.</p>
<p id="p0048" num="0048">For the purpose of the present invention, the phenotypic effects of expression of an endogenous gene in a pod DZ cell is prevented, suppressed, inhibited or reduced if the amount of mRNA and/or protein produced by the cell by expression of the endogenous gene is reduced, preferably by at least 30%, particularly by at least 75%, more particularly by at least 90%.</p>
<p id="p0049" num="0049">Plants, in which pod dehiscence is delayed to different extents, or even prevented, are produced by transforming a plant with a recombinant DNA comprising at least one pod DZ-selective chimeric gene of this invention whose expression in the plant results in the production of RNA or a protein or polypeptide which interferes to different degrees with the normal functioning of the cells of the pod dehiscence zone, for example, by reducing the phenotypic effects of expression of one or more endogenous genes that encode cell wall hydrolytic enzymes, or by killing the pod DZ cells. A delay in the onset of fruit dehiscence, whereby pre-harvest shattering of seeds can be reduced or prevented, will find its application in those plants that suffer from pre-mature (i.e., prior to harvest) seed loss.</p>
<p id="p0050" num="0050">In a preferred embodiment of the present invention the pod DZ-selective chimeric gene comprises a transcribed DNA region encoding an RNA capable of inhibiting or reducing the expression of an endogenous plant gene encoding a cell wall hydrolase selectively expressed in the cells of the pod DZ, said cell wall hydrolase comprising the amino acid sequence of the protein encoded by the nucleotide sequence of SEQ ID No 1 between the nucleotide at position 95 and the nucleotide at position 1393. The reduction of the expression of the endogenous gene can be demonstrated by the reduction of the cytoplasmic levels<!-- EPO <DP n="16"> --> of the mRNA normally produced by the endogenous gene. The endogenous gene as isolated from the plant will<!-- EPO <DP n="17"> --> hereinafter be designated as the sense gene which encodes a sense mRNA (or sense pre-mRNA, i.e., an unprocessed mRNA which may include intron regions).</p>
<p id="p0051" num="0051">The endogenous sense gene encodes an enzyme involved in cell wall hydrolysis, particularly an endo-PG. It is believed that endo-polygalacturonases, play an important role in the degradation of the middle lamella material of plant cell walls and in the process of dehiscence, and that selective inhibition of the production of such enzymes in the dehiscence zone or in the region surrounding the dehiscence zone (e.g., by expression of an antisense RNA to the endo-PG encoding mRNA) on the average delays pod shatter for at least 1 day, preferably 2-5 days.</p>
<p id="p0052" num="0052">Although the sense gene may encode any cell wall hydrolase, that is secreted by the cells of the pod DZ during the process of pod dehiscence, and that is involved in the degradation of cell wall material in the pod, dehiscence zone, such as for example a cellulase, a glucanase, or a beta-galactosidase, it is preferred that the sense gene is an endogenous pod DZ-selective gene encoding a cell wall hydrolase comprising the amino acid sequence of the protein encoded by the nucleotide sequence of SEQ ID No 1 between the nucleotide at position 95 and the nucleotide at position 1393.</p>
<p id="p0053" num="0053">Thus, in one aspect of this invention the pod DZ-selective chimeric gene of this invention encodes an antisense RNA which is complementary to at least part of a sense mRNA or sense pre-mRNA. Such antisense RNA is said to be directed to the sense RNA (or sense pre-mRNA). In this regard, the encoded antisense RNA comprises a region which is complementary to a part of the sense mRNA or sense pre-mRNA, preferably to a continuous stretch thereof of at least 50 bases in length, preferably of at least between 100 and 1000 bases in length. The upper limit for the length of the region of the antisense RNA which is complementary to the sense RNA is of course the length of the full-length sense pre-mRNA, or to the full length sense mRNA (which may or may be not processed from a sense pre-mRNA), produced by the plant cells can be used. However, the antisense RNA can be complementary to any part of the sequence of the sense pre-mRNA and/or of the processed sense mRNA: it may be complementary to the sequence<!-- EPO <DP n="18"> --> proximal to the 5' end or capping site, to part or all of the 5' untranslated region, to an intron or exon region (or to a region bridging an exon and intron) of the sense pre-mRNA, to the region bridging the noncoding and coding region, to all or part of the coding region including the 3' end of the coding region, and/or to all or part of the 3' untranslated region. In case the sense gene is a member of a gene family, it is preferred that the antisense RNA encoded by the pod DZ-selective chimeric gene of this invention contains a sequence which is complementary to a region of the sense RNA, e.g., a pod DZ-selective sense RNA, of at least 50 nucleotides and which has a percent sequence identity (see above) of less than 50 %, preferably less than 30 %, with any region of 50 nucleotides of any sense RNA encoded by any other member of the gene family.</p>
<p id="p0054" num="0054">The transcribed DNA region in the pod DZ-selective chimeric gene of this invention can also encode a specific RNA enzyme, or so-called ribozyme (see, e.g., WO89/05852), capable of highly specific cleavage of the sense mRNA or sense pre-RNA. Such ribozyme is said to be directed to the sense RNA (or sense pre-mRNA).</p>
<p id="p0055" num="0055">Expression of the endogenous cell wall hydrolase gene producing a sense mRNA in a plant can also be inhibited or repressed by a pod DZ-selective chimeric gene which encodes part or all, preferably all, of such sense RNA [Jorgensen et al. (1992), <i>AgBiotech News Info</i> <b>4</b>: 265N].</p>
<p id="p0056" num="0056">The sense RNA to which the antisense RNA or ribozyme encoded by the pod DZ-selective chimeric gene of this invention is directed is preferably a mRNA, wherein a (doublestranded) cDNA of such mRNA comprises the nucleotide sequence of SEQ ID No 1 (or SEQ ID No 10) or variants thereof. A preferred region of the cDNA corresponding to the sense RNA to which the antisense RNA or ribozyme encoded by the pod DZ-selective chimeric gene of this invention is directed comprises a nucleotide sequence of SEQ ID No. 1 starting anywhere between nucleotide 890 and 950 and ending anywhere between nucleotide 1560 and 1620, such as, but not limited to, the nucleotide sequence between nucleotides 952 and 1607. Another preferred region of the cDNA corresponding to the sense RNA to which the antisense RNA or ribozyme encoded by the pod DZ-selective<!-- EPO <DP n="19"> --> chimeric gene of this invention is directed comprise a nucleotide sequence of SEQ ID No. 1 starting anywhere between nucleotide 1280 and 1340 and ending anywhere between nucleotide 1560 and 1620, such as, but not limited to, the nucleotide sequence between nucleotides 1296 and 1607.</p>
<p id="p0057" num="0057">The promoter of the pod DZ-selective gene described above should direct expression at least in cells of the pod DZ. Indeed, because the cell wall hydrolase gene is expressed selectively in the cells of the pod DZ, the production of the antisense RNA or ribozyme encoded by the pod DZ-selective gene in cells other than the cells of the pod DZ, will not have a noticeable phenotypic effect on such cells. Examples of promoters that direct expression at least in cells of the pod DZ are constitutive plant expressible promoters such as the promoter (P35S) of the 35S transcript of Cauliflower mosaic virus (CaMV)[Guilley <i>et al.</i> (1982), <i>Cell</i> <b>30:</b> 763], or the promoter (Pnos) of the nopaline synthase gene of <i>Agrobacterium tumefaciens</i> [Depicker <i>et al.</i> (1982), <i>J. Mol. Appl. Genet.</i> <b>1</b>: 561].</p>
<p id="p0058" num="0058">In another preferred embodiment of this invention, the pod DZ-selective chimeric gene encodes an mRNA which, when produced in plant cells, is translated into a protein or polypeptide which interferes with the metabolism and/or physiology of the plant cells selected from the group consisting of:
<ol id="ol0003" compact="compact" ol-style="">
<li>(1) a ribonuclease,</li>
<li>(2) a cytotoxin,</li>
<li>(3) tryptophan monooxygenase, indole-3-acetamide hydrolase, amidohydrolase,</li>
<li>(4) the product of the <i>rolB</i> gene, and</li>
<li>(5) a mutant ETR1 protein.</li>
</ol></p>
<p id="p0059" num="0059">In most cases production of such protein or polypeptide will be undesired in cells other than the pod DZ cells and in this regard it is preferred that such chimeric genes comprise a pod DZ-selective promoter. Particular useful pod DZ-selective promoters are again the promoters from the pod DZ-selective genes described above.<!-- EPO <DP n="20"> --></p>
<p id="p0060" num="0060">In one aspect of this invention the pod DZ-selective chimeric gene of this inventon thus comprises a transcribed DNA region encoding tryptophan monooxygenase and/or indole-3-acetamide hydrolase, encoded by the <i>Agrobacterium tumefaciens</i> T-DNA gene 1 (<i>iaaM</i>) and/or gene 2 (<i>iaaH</i>), respectively [Gielen et al. (1984), <i>The EMBO J.</i> <b>3</b>: 835], or amidohydrolase, encoded by the <i>Arabidopsis thaliana</i> ILR1 gene, which releases active indole-3-acetic acid (IAA) from IAA-conjugates [Bartel and Fink (1995), <i>Science</i> <b>268</b>: 1745]. In view of the observed decline in IAA levels prior to pod dehiscence (see Example 1), it is thought that production of such auxin increasing proteins selectively in the pod DZ cells of a plant, will not result in the killing of the cells due to overproduction of IAA, but will rather result in the maintenance and/or restoration of the IAA levels sirbstantially as found before the observed decline. This delays the onset of pod dehiscence, through a prolonged inhibition by IAA of production and/or activity of cell wall hydrolytic enzyme normally produced by the cells in the dehiscence zone.</p>
<p id="p0061" num="0061">Alternatively the transcribed DNA region of the pod DZ-selective chimeric gene of this invention can comprise the open reading frame of the <i>Agrobacterium rhizogenes rolB</i> gene [Fumer et al. (1986), <i>Nature</i> <b>319:</b> 422]. Expression of such pod DZ-selective chimeric gene in a plant will result in an increase of the sensitivity of the plant cells towards auxin through the production of the rolB gene product in cells of the pod DZ thereby countering the normal decline in IAA concentration in the DZ prior to pod shattering.</p>
<p id="p0062" num="0062">In another aspect of the present invention, the pod DZ-selective chimeric gene of this invention comprises<!-- EPO <DP n="21"> --> a transcribed DNA region encoding a protein whose activity results in a decrease of the sensitivity towards ethylene of the plant cells in which it is produced, particularly the open reading frame of a dominant, ethylene-insensitive, mutant allele of the <i>Arabidopsis thaliana</i> ETR1 gene, such as ETR1-1 [Chang et al. (1993), <i>Science</i> <b>262</b>: 539]. A plant in which such pod DZ-selective chimeric gene is expressed produces a mutant ethylene receptor (the ETR1-1 protein) selectively in the cells of the pod DZ and these cells therefore become insensitive towards the phytohormone ethylene and do not respond (metabolically) to changes in the concentration of the hormone, such as the ethylene dimacteric observed prior to the onset of pod dehiscence. It is thought that alternatively, a transcribed DNA region comprising an open reading frame of a dominant, ethylene-insensitive, mutant allele of alternative class I ethylene receptors can be used to the same effect. In another example of such a pod DZ-selective chimeric gene, conferring ethylene-insensitivity to the plants cells expressing the pod DZ-selective chimeric gene, a transcribed DNA region comprising an open reading frame of a dominant, ethylene-insensitive, mutant allele of class II ethylene receptors, such as the <i>Arabidopsis thaliana</i> ERS gene [Hua et al. (1995), <i>Science</i> 269: 1712] or the tomato NR gene [Wilkinson et al. (1995), <i>Science</i> <b>270</b>:1807] can be used for the same purpose.<!-- EPO <DP n="22"> --></p>
<p id="p0063" num="0063">It is further assumed that the products encoded by the CTR1, EIN2 and EIN3 genes, involved in the ethylene signal transduction pathway, act downstream of the receptors. For <i>CTR1, EIN2</i> and <i>EIN3</i> the genes have been cloned [Ecker (1995), <i>Science</i> <b>268</b>: 667]. Modulation of the expression of the latter genes in the pod dehiscence zone, e.g., by antisense RNA or ribozyme RNA, transcribed under control of a pod DZ-specific promoter, which is targetted towards the mentioned genes, will also influence the sensitivity towards ethylene.</p>
<p id="p0064" num="0064">In another aspect of this invention the pod DZ-selective chimeric gene of this invention comprises a transcribed DNA region encoding ribonucleases such as RNase T1 and especially bamase [Hartley (1988), J. Mol. Biol. <b>202</b>: 913]; cytotoxins such as the A-domain of diphtheria toxin [Greenland et al. (1983), <i>Proc. Natl. Acad. Sci. USA</i> <b>80</b>: 6853] or the <i>Pseudomonas</i> exotoxin A. Several other DNA sequences encoding proteins with cytotoxic properties can be used in accordance with their known biological properties. Examples include, but are not limited to, DNA sequences encoding proteases such as papain; glucanases; lipases such as phospholipase A2; lipid peroxidases; methylases such as the <i>E. coli</i> Dam methylase; DNases such as the EcoRI endonuclease; plant cell wall inhibitors, and the like.</p>
<p id="p0065" num="0065">In the pod DZ-selective chimeric gene of this invention it is preferred that the 5' untranslated region of encoded RNA is normally associated with the promoter,<!-- EPO <DP n="23"> --> such as a pod DZ-selective promoter, of the chimeric gene. However, the 5' untranslated region may also be from another plant expressible gene. Thus, it is preferred that a pod DZ-selective chimeric gene of this invention comprises the complete 5' regulatory region (including the 5' untranslated region) of a pod DZ-selective gene. A particularly useful 5' regulatory region is a region of SEQ ID No 13, immediately upstream of position 1,329, preferably a region of at least 490 bp, more preferably a region extending to the first <i>Sph</i>l site upstream of position 2,329.</p>
<p id="p0066" num="0066">The pod DZ-selective chimeric genes of this invention preferably also comprise 3' untranslated regions, which direct correct polyadenylation of mRNA and transcription termination in plant cells. These signals can be obtained from plant genes such as polygalacturonase genes, or they can be obtained from genes that are foreign to the plants. Examples of foreign 3' transcription termination and polyadenylation signals are those of the octopine synthase gene [De Greve et al. (1982), <i>J. Mol. Appl. Genet.</i> <b>1</b>:499], of the nopaline synthase gene [Depicker et al. (1982). <i>J. Mol. Appl. Genet.</i> <b>1</b>: 561] or of the T-DNA gene 7 [Velten and Schell (1985), <i>Nucl. Acids Res.</i><b>13</b>: 6998] and the like.</p>
<p id="p0067" num="0067">Preferably, the recombinant DNA comprising the pod DZ-selective chimeric gene also comprises a conventional chimeric marker gene. The chimeric marker gene can comprise a marker DNA that is; under the control of, and operatively linked at its 5' end to, a plant-expressible promoter, preferably a constitutive promoter, such as the CaMV 35S promoter, or a light inducible promoter such as the promoter of the gene encoding the small subunit of Rubisco; and operatively linked at its 3' end to suitable plant transcription termination and polyadenylation signals. The marker DNA preferably encodes an RNA, protein or polypeptide which, when expressed in the cells of a plant, allows such cells to be readily separated from those cells in which the marker DNA is not expressed. The choice of the marker DNA is not critical, and any suitable marker DNA can be selected in a well known manner. For example, a marker DNA can encode a protein that provides a distinguishable color to the transformed plant cell, such as the A1 gene (Meyer et al. (1987), <i>Nature</i> <b>330</b>: 677), can provide herbicide resistance to the transformed plant cell, such as the bar gene, encoding resistance to<!-- EPO <DP n="24"> --> phosphinothricin (EP 0,242,246), or can provided antibiotic resistance to the transformed cells, such as the <i>aac(6')</i> gene, encoding resistance to gentamycin (WO94/01560).</p>
<p id="p0068" num="0068">The pod DZ-selective promoters of this invention are believed to be highly specific in activity or effect with regard to directing gene expression in cells of the pod DZ. However the characteristics (e.g., tissue-specificity) of a promoter contained in a chimeric gene may be slightly modified in some plants that are transformed with such chimeric gene. This can, for example, be attributed to "position effects" as a result of random integration in the plant genome.</p>
<p id="p0069" num="0069">Therefore in some plants transformed with the pod DZ-selective chimeric gene of this invention low-level expression of the chimeric gene may be observed in certain non-pod DZ cells. Thus, optionally, the plant genome can also be transformed with a second chimeric gene comprising a second transcribed DNA region, that is under control of a second plant-expressible promoter and that encodes a RNA, protein or polypeptide which is capable of counteracting, preventing or inhibiting the activity of the gene product of the pod DZ-selective chimeric gene. If the DZ-selective chimeric gene encodes bamase it is preferred that the second chimeric gene encodes a barstar, i.e., an inhibitor of bamase [Hartley (1988), <i>J</i>. <i>Mol. Biol.</i> <b>202</b>: 913]. Other useful proteins encoded by the second chimeric genes are antibodies or antibody fragments, preferably single chain antibodies, that are capable of specific binding to the protein encoded by the pod DZ-selective chimeric gene whereby such protein is biologically inactivated.</p>
<p id="p0070" num="0070">Preferably the second promoter is capable of driving expression of the second transcribed DNA region at least in non-pod DZ cells of the plant to counteract, prevent or inhibit the undesired effects of low expression of the pod DZ-selective chimeric gene in such cells in some transformed plants. Examples of useful second promoters are the CaMV minimal 35S promoter [Benfey and Chua (1990), <i>Science</i> 250: 959] or the promoter of the nopaline synthase gene of <i>Agrobacterium tumefaciens</i> T-DNA [Depicker et al. (1982), <i>J. Mol. Appl. Genet.</i> <b>1</b>: 561]. Other useful promoters are promoters from genes that are known not to be active in the pod DZ, such as <i>Brassica napus</i> genes encoding a mRNA from which<!-- EPO <DP n="25"> --> a cDNA can be prepared that comprises the sequence of SEQ ID. No 7, SEQ ID No 9, or SEQ ID No 11.</p>
<p id="p0071" num="0071">In plants the second chimeric gene is preferably in the same genetic locus as the pod DZ-selective chimeric gene so as to ensure their joint segregation. This can be obtained by combining both chimeric genes on a single transforming DNA, such as a vector or as part of the same T-DNA. However, in some cases a joint segregation is not always desirable. Therefore both constructs can be present on separate transforming DNAs, so that transformation might result in the integration of the two constructs at different location in the plant genome.</p>
<p id="p0072" num="0072">In still a further embodiment of the present invention, a plant with modified dehiscence properties can be obtained from a single plant cell by transforming the cell in a known manner, resulting in the stable incorporation of a pod DZ-selective chimeric gene of the invention into the nuclear genome.</p>
<p id="p0073" num="0073">A recombinant DNA comprising a pod DZ-selective chimeric gene can be stably incorporated in the nuclear genome of a cell of a plant, particularly a plant that is susceptible to <i>Agrobacterium</i>-mediated transformation. Gene transfer can be carried out with a vector that is a disarmed Ti-plasmid, comprising a pod DZ-selective chimeric gene of the invention, and carried by <i>Agrobacterium.</i> This transformation can be carried out using the procedures described, for example, in EP 0,116,718. Ti-plasmid vector systems comprise a pod DZ-selective chimeric gene between the T-DNA border sequences, or at least to the left of the right T-DNA border. Alternatively, any other type of vector can be used to transform the plant cell, applying methods such as direct gene transfer (as described, for example, in EP 0,233,247), pollen-mediated transformation (as described, for example, in EP 0,270,356, WO85/0185 and US 4,684,611), plant RNA virus-mediated transformation (as described, for example, in EP 0,067,553 and US 4,407,956), liposome-mediated transformation (as described, for example, in US 4,536,475), and the like.</p>
<p id="p0074" num="0074">Other methods, such as microprojectile bombardment as described, for example, by Fromm et al. [(1990), <i>Bio</i>/<i>Technology</i> <b>8</b>: 833] and Gordon-Kamm et<!-- EPO <DP n="26"> --> al. [(1990), <i>The Plant Cell</i> <b>2</b>: 603], are suitable as well. Cells of monocotyledonous plants, such as the major cereals, can also be transformed using wounded or enzyme-degraded intact tissue capable of forming compact embryogenic callus, or the embryogenic callus obtained thereof, as described in WO92/09696. The resulting transformed plant cell can then be used to regenerate a transformed plant in a conventional manner.</p>
<p id="p0075" num="0075">The obtained transformed plant can be used in a conventional breeding scheme to produce more transformed plants with the same characteristics or to introduce the pod DZ-selective chimeric gene of the invention in other varieties of the same or related plant species. Seeds obtained from the transformed plants contain the pod DZ-selective chimeric gene of the invention as a stable genomic insert.</p>
<p id="p0076" num="0076">The following Examples describe the isolation and characterization of a DZ-selective gene from <i>Brassica napus,</i> the identification of DZ-selective promoter, and the use of such a promoter for the modification of dehiscence properties in plants. Unless stated otherwise in the Examples, all recombinant DNA techniques are carried out according to standard protocols as described in Sambrook et al. (1989) <i>Molecular Cloning: A Laboratory Manual,</i> Second Edition, Cold Spring Harbor Laboratory Press, NY and in Volumes 1 and 2 of Ausubel et al. (1994) <i>Current Protocols in Molecular Biology, Current Protocols</i>, USA. Standard materials and methods for plant molecular work are described in <i>Plant Molecular Biology Labfax</i> (1993) by R.D.D. Croy, jointly published by BIOS Scientific Publications Ltd (UK) and Blackwell Scientific Publications, UK.</p>
<p id="p0077" num="0077">In the examples and in the description of the invention, reference is made to following sequences of the Sequence Listing:
<tables id="tabl0001" num="0001">
<table frame="none">
<tgroup cols="2" colsep="0" rowsep="0">
<colspec colnum="1" colname="col1" colwidth="26mm" colsep="0"/>
<colspec colnum="2" colname="col2" colwidth="140mm" colsep="0"/>
<tbody>
<row>
<entry namest="col1" nameend="col1" align="left" valign="top">SEQ ID No 1 :</entry>
<entry namest="col2" nameend="col2" align="left" valign="top">DZ-selective cDNA encoding a endo-polygalacturonase of Brassica napus</entry></row>
<row>
<entry namest="col1" nameend="col1" align="left" valign="top">SEQ ID No 2 :</entry>
<entry namest="col2" nameend="col2" align="left" valign="top">oligonucleotide PG1</entry></row>
<row>
<entry namest="col1" nameend="col1" align="left" valign="top">SEQ ID No 3 :</entry>
<entry namest="col2" nameend="col2" align="left" valign="top">oligonucleotide PG2</entry></row>
<row>
<entry namest="col1" nameend="col1" align="left" valign="top">SEQ ID No 4 :</entry>
<entry namest="col2" nameend="col2" align="left" valign="top">oligonucleotide PG3</entry></row><!-- EPO <DP n="27"> -->
<row>
<entry namest="col1" nameend="col1" align="left" valign="top">SEQ ID No 5 :</entry>
<entry namest="col2" nameend="col2" align="left" valign="top">oligonucleotide PG5</entry></row>
<row>
<entry namest="col1" nameend="col1" align="left" valign="top">SEQ ID No 6 :</entry>
<entry namest="col2" nameend="col2" align="left" valign="top">PCR Fragment BPG32-26</entry></row>
<row>
<entry namest="col1" nameend="col1" align="left" valign="top">SEQ ID No 7 :</entry>
<entry namest="col2" nameend="col2" align="left" valign="top">PCR Fragment KPG32-8</entry></row>
<row>
<entry namest="col1" nameend="col1" align="left" valign="top">SEQ ID No 8 :</entry>
<entry namest="col2" nameend="col2" align="left" valign="top">PCR Fragment LPG12-16</entry></row>
<row>
<entry namest="col1" nameend="col1" align="left" valign="top">SEQ ID No 9 :</entry>
<entry namest="col2" nameend="col2" align="left" valign="top">PCR Fragment LPG32-24</entry></row>
<row>
<entry namest="col1" nameend="col1" align="left" valign="top">SEQ ID No 10 :</entry>
<entry namest="col2" nameend="col2" align="left" valign="top">PCR Fragment LPG32-25</entry></row>
<row>
<entry namest="col1" nameend="col1" align="left" valign="top">SEQ ID No 11 :</entry>
<entry namest="col2" nameend="col2" align="left" valign="top">PCR Fragment LPG32-32</entry></row>
<row>
<entry namest="col1" nameend="col1" align="left" valign="top">SEQ ID No 12 :</entry>
<entry namest="col2" nameend="col2" align="left" valign="top">T-DNA of pGSV5</entry></row>
<row>
<entry namest="col1" nameend="col1" align="left" valign="top">SEQ ID No 13 :</entry>
<entry namest="col2" nameend="col2" align="left" valign="top">sequence of genomic clone comprising the pod DZ-selective promoter region driving expression of an endopolygalacturonase gene of <i>Brassica napus</i></entry></row></tbody></tgroup>
</table>
</tables></p>
<p id="p0078" num="0078">In order to further illustrate the present invention and advantages thereof, the following specific examples are given, it being understood that the same are intended as illustrative and in nowise limitative.</p>
<heading id="h0004"><b><u style="single">EXAMPLE 1</u></b></heading>
<heading id="h0005"><b><u style="single">Characterization of pod dehiscence during pod development.</u></b></heading>
<heading id="h0006"><b>Endogenous phytohormone profiles during pod development.</b></heading>
<p id="p0079" num="0079"><i>Brassica napus cv Fido</i> plants were grown in an unheated greenhouse. At 12 days after germination plants were transferred to, and further grown in, 1000 cm3 compost. Pods were collected at one week intervals from two to eight weeks after anthesis. The pods were taken from the base of the terminal one of the first three axillary racemes. The pods were separated into dehiscence zone, pod wall and seeds.</p>
<p id="p0080" num="0080">The samples were ground with a mortar and pestle and then extracted for 16 hours at -20°C in a total volume of 80% methanol. Purification and analysis of phytohormones was carried out essentially as described [Bialek and Cohen (1989), <i>Plant Physiol.</i> <b>90</b>: 398; Prinsen et al. (1991), in: <i>A Laboratory Guide for Cellular and Molecular Plant Biology.</i> Ed. Negrutiu and Gharti-Chhetri. Birkhäuser<!-- EPO <DP n="28"> --> Verlag, Basel/Boston/Berlin pp.175-185, pp.323-324; Chauvaux et al. (1993), <i>J. Chromatogr.</i> A <b>657</b>: 337].</p>
<p id="p0081" num="0081">Different parts of the pods (pod wall, dehiscence zone and seeds) were screened for endogenous concentrations of the ethylene precursor 1-aminocyclopropane-1-carboxylic acid (ACC) and conjugates thereof as well as for indole-3-acetic acid (IAA) and conjugates thereof.</p>
<p id="p0082" num="0082">A peak in ethylene evolution [see also Meakin and Roberts (1990), <i>J. Exp. Bot.</i> <b>41:</b> 1003] was observed immediately before pod shattering; this peak was correlated with observed peaks of free ACC. Especially in the dehiscence zone a decline in IAA concentrations (free as well as conjugated forms) was observed, just before the onset of pod opening. This decline in IAA concentration was specifically correlated with an increased cellulase activity in the dehiscence zone.</p>
<p id="p0083" num="0083">In a further experiment ethylene production was inhibited by treating the pods with aminoethoxyvinylglycine (AVG), a competitive inhibitor of the enzyme ACC-synthase. AVG was applied 28 days after anthesis at 500 mg/l. This treatment resulted in a 40-50 % reduction of ethylene production in the entire pod and was accompanied by a delay of pod wall senescence of approximately 4 days. Decreased endogenous ACC concentrations in both dehiscence zone and seeds of the treated pods correlated with the reduced ethylene production. In the other tissues analysed (pod wall, septum and the zone between dehiscence zone and pod wall) no such decrease in ACC concentrations or synthesis could be demonstrated. A decrease in endogenous IAA content in the dehiscence zone preceding pod opening was also observed in these experiments both in control and in AVG-treated plants.</p>
<p id="p0084" num="0084">To examine the auxin involvement in pod shattering, the synthetic auxin 4-chlorophenoxyacetic acid (4CPA) was used to manipulate auxin levels. 4CPA was applied 35 days after anthesis as a spray at 150 mg/l in order to artificially keep auxin concentration at a high level during the entire period. This resulted in a distinct retardation in pod shatter tendency (see Table 1), as well as a delay of pod wall senescence of about two weeks. No effect was observed on the<!-- EPO <DP n="29"> --> endogenous phytohormone concentrations. Beta-Glucanase activity however was markedly decreased in the dehiscence zone. These results are clearly indicative of the inhibitory effect of auxins on the production and/or activity of beta-glucanase.</p>
<p id="p0085" num="0085">The decline in auxin is a major trigger of pod shatter.
<tables id="tabl0002" num="0002">
<table frame="all">
<title>Table 1: Force (in 10-3 N) needed to initiate and propagate pod opening as measured in the Cantilever bending test [Kadkol et al. [(1986), Aust. J. Bot. <b>34</b>: 595] with pods (8% moisture) of oilseed rape cv Fido. Tested plants were either untreated, sprayed with AVG to reduce ethylene values, or sprayed with 4CPA to prevent the auxin drop. (SED: Standard Error on Differences; df: degree of freedom)</title>
<tgroup cols="5" colsep="1" rowsep="1">
<colspec colnum="1" colname="col1" colwidth="101mm" colsep="1"/>
<colspec colnum="2" colname="col2" colwidth="19mm" colsep="1"/>
<colspec colnum="3" colname="col3" colwidth="13mm" colsep="1"/>
<colspec colnum="4" colname="col4" colwidth="14mm" colsep="1"/>
<colspec colnum="5" colname="col5" colwidth="21mm" colsep="1"/>
<thead>
<row>
<entry namest="col1" nameend="col1" align="left" valign="top"/>
<entry namest="col2" nameend="col2" align="center" valign="top">untreated</entry>
<entry namest="col3" nameend="col3" align="center" valign="top">AVG</entry>
<entry namest="col4" nameend="col4" align="center" valign="top">4CPA</entry>
<entry namest="col5" nameend="col5" align="center" valign="top">SED (27df)</entry></row></thead>
<tbody>
<row>
<entry namest="col1" nameend="col1" align="left" valign="top">To initiate crack</entry>
<entry namest="col2" nameend="col2" valign="top" align="char" char="." charoff="46">143.6</entry>
<entry namest="col3" nameend="col3" valign="top" align="char" char="." charoff="44">170.8</entry>
<entry namest="col4" nameend="col4" valign="top" align="char" char="." charoff="44">194.9</entry>
<entry namest="col5" nameend="col5" valign="top" align="char" char="." charoff="38">14.4</entry></row>
<row>
<entry namest="col1" nameend="col1" align="left" valign="top">To propagate crack</entry>
<entry namest="col2" nameend="col2" valign="top" align="char" char="." charoff="46">167.1</entry>
<entry namest="col3" nameend="col3" valign="top" align="char" char="." charoff="44">171.4</entry>
<entry namest="col4" nameend="col4" valign="top" align="char" char="." charoff="44">222.6</entry>
<entry namest="col5" nameend="col5" valign="top" align="char" char="." charoff="38">17.21</entry></row></tbody></tgroup>
</table>
</tables><!-- EPO <DP n="30"> --></p>
<heading id="h0007"><b>Demonstration of polygalacturonate-degrading enzyme activity in pod dehiscence zones.</b></heading>
<p id="p0086" num="0086">Pods of oilseed rape cv Fido were harvested at 6.5 weeks after anthesis, stripped of the carpels and seeds, and crude enzyme extracts were prepared from tissues surrounding the dehiscence zones, including the replum with a vascular bundle and the thin membrane separating the two locules of the silique. Extracts were subsequently tested with respect to their action against polymeric substrates (uronic acids), using molecular weight down-shift assays, based on gel-permeation chromatography of substrate incubated with a boiled (used as reference) and active enzyme preparation respectively. The assay in particular detects enzymes with endo-activity as removal of single monosaccharides in an exo-fashion only changes molecular weight distribution of the polymeric substrate very slowly. Analysis for uronic acids was carried out essentially as described by Blumenkrantz and Asboe-Hansen [(1973), <i>Anal. Biochem.</i> <b>54</b>: 484]. The assay was used here only to demonstrate the presence of enzyme activities in a strictly qualitative sense.</p>
<p id="p0087" num="0087">DZ preparations from oilseed rape pods contain all enzyme activities required for a full depolymerization of pectic polymers of low degree of methylation. It was found that one component of the enzyme mixture was specifically acting on polygalacturonate polymers. It was further demonstrated that only endo-polygalacturonase among known plant enzymes is responsible for the molecular weight down-shift of the polygalacturonate preparations used.</p>
<p id="p0088" num="0088">It can be concluded that endo-polygalacturonase plays an important role in the extensive degradation of middle lamella material observed during pod dehiscence.</p>
<heading id="h0008"><b>Anatomical observations during the process of dehiscence</b></heading>
<p id="p0089" num="0089">Detailed examination of the structure of pod tissues has given more insight in the anatomical changes associated with the biochemical processes that take place in the dehiscence zone. It was observed by electron microscopy that<!-- EPO <DP n="31"> --> rapid dehydration of the pod wall immediately precedes the degradation of parenchymatous cells situated in the dehiscence zone, mesocarp, septum and in the seed abcission zone. Initial signs of breakdown were shown by swelling of the cell walls. Subsequent cell-separation was seen only in the dehiscence zone, and was observed to take place along the line of the middle lamella to be followed by the dispersion of the microfibrils of the cell wall. Finally, all the cells of the dehiscence zone were observed to separate while the two valves of the pod remained attached only by the vascular strands which pass through the dehiscence zone. Analysis using electron microscopy revealed very dramatic degradation of the middle lamella during pod opening while the primary cell wall was left essentially intact but for some thinning and softening processes. These observations indicate that any processes in the primary cell wall are accessory to the degradation of the middle lamella.</p>
<p id="p0090" num="0090">The complete dissolution of the middle lamella of cells in the dehiscence zone indicates the presence of pectin degrading enzymes such as endoPG. While such enzymes degrade charged portions of the middle lamella pectins, other polysaccharide hydrolases, with affinity towards neutral polymers, are involved tocomplete the depolymerization of the middle lamella.</p>
<p id="p0091" num="0091">A beta-galactanase and a beta-glucanase were purified to homogeneity. Detailed investigation of the substrate specificity indicated that these enzymes are involved in thinning of the primary cell wall in the dehiscence zone.</p>
<heading id="h0009"><b><u style="single">EXAMPLE 2</u></b></heading>
<heading id="h0010"><b><u style="single">Isolation of a DZ-selective endo-polyaalacturonase cDNA clone from <i>Brassica napus.</i></u></b></heading>
<p id="p0092" num="0092">Poly-A+ mRNA of pod dehiscence zones of <i>Brassica napus</i> cv Topaz plants was prepared as follows. Twenty grams of tissue (leaves, dehiscence zones, pod walls, roots or stems) were ground in liquid nitrogen and homogenized for 30 seconds in a Waring blender with 100 ml of extraction buffer (4M guanidinium thiocyanate, 25 mM sodium citrate, pH 7.0, 0.5% sarkosyl, 0.1 M<!-- EPO <DP n="32"> --> 2-mercaptoethanol). The homogenate was transferred to a fresh tube and 1/10 volume of 2M sodium acetate, pH 4.0, and 1 volume of TE saturated phenol/chloroform was added. The solution was shaked vigorously, cooled on ice for 15 min. and centrifuged at 10,000 x g for 15 min at 4 °C. The supematant was re-extracted with phenol/chloroform as described above. An equal volume of isopropanol was added to the re-extracted supernatant and RNA was precipitated by an overnight incubation at -20 °C. After centrifugation at 10,000 x g for 15 min, the RNA pellet was dissolved in 2 ml of denaturation buffer. Fourteen ml of 4M LiCl was then added and the solution kept in an ice-bath overnight. The RNA was pelleted by centrifugation at 10,000 x g for 15 min, washed in 80% ethanol, dried and dissolved in 1 ml of water. Poly-A+ RNA was isolated on an oligo-d(T) sepharose column according to the manufacturer's guidelines (Boehringer, Mannheim).</p>
<p id="p0093" num="0093">Random or oligo-d(T) primed first strand cDNA synthesis was performed using M-MLV reverse transcriptase and 6 µg of total poly-A+ RNA as prepared aboveaccording to conditions outlined by the manufacturer (Life Technologies/BRL). Firststrand cDNAs were used as template DNA for further PCR reactions.</p>
<p id="p0094" num="0094">Four degenerated primers were designed based on conserved regions from published polygalacturonase (PG) amino acid sequences from tomato [DellaPenna et al. (1986), <i>Proc. Natl. Acad. Sci. USA</i> 83:6420; Grierson et al. (1986), <i>Nucl. Acids Res.</i> <b>14</b>: 8595], maize [Niogret et al. (1991), <i>Plant Mol. Biol.</i> <b>17</b>: 1155], avocado and Oenothera [Brown and Crouch (1990), <i>The Plant Cell <b>2:</b></i> 263]. The sequences of the four primers used (PG1, PG2, PG3 and PG5) are shown in SEQ ID NoS 2-5. A restriction enzyme site for <i>Eco</i>RI was introduced at the 5-end of the two upstream primers PG1 and PG3 and a <i>Bam</i>HI site was introduced at the 5-end of the two downstream primers PG2 and PG5.</p>
<p id="p0095" num="0095">All PCR reactions had the following final composition: 50 mM KCI, 10 mM Tris-HCl, pH 8.3, 1.5 mM MgCl, and 0.001 % (w/v) gelatin, 100 pmoles of degenerated primers and 1 U of <i>Taq</i> DNA polymerase in a 50 µl reaction volume.<!-- EPO <DP n="33"> --> After an initial denaturation of template DNA at 95°C for 3 minutes in 1xPCR reaction buffer, the PCR reaction was initiated by adding 1U of <i>Taq</i> DNA polymerase in 1xPCR buffer (hot start PCR) using the following conditions: 1 min. at 95°C. 1 min. at 45°C and 1 min. at 72°C for 35 cycles followed by 72°C for 3 min. For hot start nested PCR 2 I of a PCR reaction was applied as template in a new PCR reaction. The PCR products were chloroform extracted and ethanol precipitated, redissolved in TE and digested with the restriction enzymes BamHI and EcoRI. The restricted PCR products were purified from low melting agarose, and cloned into pGEM-7z cut with BamHI and EcoRI. DNA sequences of the PCR fragments were obtained by the dideoxy chain termination method using Sequenase version 2.0 (Pharmacia).</p>
<p id="p0096" num="0096">The longest PCR fragment was obtained by using the PG1/PG5 primer combination. Hot start nested PCR was performed with the PG3/PG2, PG1/PG2 or PG3/PG5 primer combinations using a small aliquot of the PG1/PG5 PCR reaction as a template. Seven highly divergent PG-related clones were identified by sequencing of the PCR products, indicating the presence of at least seven different PG isoforms. Three forms were obtained from a single tissue only, namely Ipg32-25 (SEQ ID No 10) from dehiscence zones, kpg32-8 (SEQ ID No 7) from pod walls and bpg32-26 (SEQ ID No 6) from leaves. Lpg32-32 (SEQ ID No 11), Ipg32-24 (SEQ ID No 9) were found only in the two pod tissues, whereas Ipg12-16 (SEQ ID No 8) was obtained from all three tissues analyzed. It should be noted, that Ipg35-8 (containing the DNA sequence of SEQ ID No 1 from position 884 to 1,245) was the only type identified in the dehiscence zone when the PG3/PG5 primer combination was used in a nested PCR reaction.</p>
<p id="p0097" num="0097">The expression of the PG-related PCR clone Ipg35-8 in roots, stems, leaves and hypocotyls as well as during pod development was investigated by Northern analysis as follows. Total RNA of individual tissues was separated by gel electrophoresis in 0.66 M formaldehyde/1%agarose gel [Sambrook et al. (1989), <i>supra</i>]. RNA was transferred onto Hybond-N filters and fixed to the filter by UV-irradiation. The filters were prehybridized for 4 hours in 5 x Denhardt, 25 mM Na2HPO4, 25 mM NaH2PO4, 0.1% pyrophosphate, 750mM NaCl, 5mM EDTA and 100 µg/ml denatured herring sperm DNA at 68°C. The PCR products<!-- EPO <DP n="34"> --> were radioactively labelled and were heat-denatured and added directly to the pre-hybridization buffer and hybridization was then continued for 16 hours at 68°C. The filter was washed according to Sambrook et al. [(1989), supra] where the final wash was carried out at 68°C in 0.2 x SSC, 0.1 % SDS. The filters were autoradiographed at -80°C using an intensifying screen.</p>
<p id="p0098" num="0098">No transcripts hybridizing to the Ipg35-8 clone could be detected in total RNA isolated from roots, stems, leaves and hypocotyls However, the Ipg35-8 clone hybridized to a 1.6-1.7 kb transcript that is exclusively expressed in the dehiscence zone during all stages analyzed and was found to increase dramatically in abundance after week 5.</p>
<p id="p0099" num="0099">A DZ-selective cDNA library was constructed in Lambda ZAP® II insertion vectors (Stratagene) using 5 µg of poly-A+ RNA isolated from dehiscence zones 6 weeks after anthesis. cDNAs larger than 1 kbp were purified from a low temperature melting agarose gel and ligated into the Lambda ZAP® II vector. The primary library consisted of 1.25 x 106 pfu with an averaged cDNA insert size of app. 1.5 kbp. Library screening was done according to standard procedures at high stringency [Sambrook et al. (1989), <i>supra</i>].</p>
<p id="p0100" num="0100">cDNAs were sequenced using Sequenase v. 2.0 (Amersham). Sequence analysis was performed with the GCG sequence analysis software package v. 7 [Devereux et al. (1984), <i>Nucl. Acids Res.</i> <b>12:</b> 387].</p>
<p id="p0101" num="0101">Screening 300,000 plaques with the Ipg35-8 PCR-fragment as probe gave approximately 200 positive hybridization signals. Five strongly hybridizing plaques were purified to homogeneity. After excision of the insert DNA from the lambda vector, restriction enzyme analysis showed the cDNA inserts to be approximately 1600 bp in all cDNA clones except one, which only had an insert of 1300 bp. Restriction enzyme mapping of the 4 largest cDNA inserts (designated as X. 5, 9 and 11 respectively) showed minor differences between the 4 cDNA inserts.</p>
<p id="p0102" num="0102">Most noteworthy is the presence of a <i>Nsi</i>I restriction enzyme site in cDNA clones X and 11 and the presence of a <i>Hind</i>II site in cDNA clone 9. In contrast,<!-- EPO <DP n="35"> --> none of these restriction sites are present in cDNA clone 5. Partial sequencing of the 5' and 3' cDNA ends revealed additional sequence variations including small deletions/insertions between the different cDNA clones. These results indicate the expression in the dehiscence zone of different but highly homologous PG-encoding genes. The sequence data also showed that the larger 4 cDNA inserts all contained the complete coding sequence for the PG protein.</p>
<p id="p0103" num="0103">The complete sequence of cDNA clone X and the deduced amino acid sequence of its largest open reading frame is shown in SEQ ID No 1. The open reading frame encodes a protein of 433 amino acids in size with an estimated molecular weight of 46.6 kD and with considerable similarity to known endo-polygalacturonases. Similar to other cell wall hydrolases the presumed DZ-selective endo-PG is initially produced as a precursor containing a N-terminal signal peptide which is cleaved off co-translationally. The most likely cleavage site is located between amino acids 23 and 24 and gives rise to a mature protein with an estimated molecular weight of 44.2 kD.</p>
<p id="p0104" num="0104">Northern analysis, using cDNA clone X as a probe, confirmed and extended the previously obtained expression pattern. Total RNA was prepared as described from different tissues of the pods (the dehiscence zone, the pod walls, seeds and septum) at 5 time points (2, 3, 5, 7 and 9 weeks after anthesis - WAA). 5 µg of total RNA was seperated by gel-electrophoresis and hybridized with the radiolabelled cDNA of SEQ ID No 1 as a probe under the stringent conditions descibed above. The autoradiogram was developed after overnight exposure. At 2 WAA, no signal was detectable; at 3 WAA a faint signal was observed. Based on densitometry scannings and readings, the expression level measured at time point 5 WAA was about 3.5x the amount seen at 3 WAA; at 7 WAA was about 7x the amount seen at 3 WAA; and at 9 WAA was about 12 times the amount seen at 3 WAA. No signal was detected in the pod walls or seeds. Faint expression (comparable with the level in the DZ at 3 WAA) was measured in the septum at 9 WAA.</p>
<p id="p0105" num="0105">The RNA used in this experiment has been extracted from the respective tissues of plants for which the pod development took about 9 weeks.<!-- EPO <DP n="36"> --></p>
<heading id="h0011"><b><u style="single">EXAMPLE 3</u></b></heading>
<heading id="h0012"><b><u style="single">Isolation of a DZ-selective promoter from a B. napus genomic clone corresponding to the cDNA clone Ipg 35-8.</u></b></heading>
<p id="p0106" num="0106">A commercially available lambda EMBL3 <i>Brassica napus</i> cv. Bridger genomic library (Clontech Laboratories, Inc.) in <i>Escherichia coli</i> strain NM538 was screened as follows. After transfer to Hybond-N nylon membranes, the Ipg35-8 cDNA was radioactively labelled using random priming, and the filters were hybridized under high stringency conditions in 5xSSPE, 5xDenhardt, 0.5 % SDS, 50 µg/ml herring DNA (1×SSPE: 0.18 M NaCl, 10 mM sodium phosphate, pH 7.7, 1 mM EDTA) and washed under high stringency conditions (68°C, 0.1xSSPE, 0.1 % SDS in the final wash). Approximately 600,000 plaques were screened and eleven hybridizing plaques were isolated. Two hybridizing plaques, lambda 2 and 11, were rescreened twice. Following the second rescreening phage lysates were made from lambda 2 and 11 on <i>E. coli</i> NM538 grown without maltose. DNA preparations from lambda 2 and lambda 11 were digested with <i>Sal</i>I, subjected to gel electrophoresis and transferred to Hybond-N nylon membrane. Hybridization with the labelled Ipg35-8 cDNA clone, resulted in identical hybridization patterns for both clones. A strongly hybridizing 6.3 kb <i>Sa</i>/I fragment was isolated from lambda 11 and inserted into pUC18, resulting in the master clone 6.3Sal. In order to confirm 6.3Sal as corresponding to Ipg35-8, a sequencing primer was designed enabling the determination of a DNA stretch encoding two unique amino acids present in Ipg35-8. Dideoxy sequencing by the Sanger method confirmed that the isolated genomic clone 6.3Sal was in this respect identical to the Ipg35-8 cDNA. Restriction mapping of this clone demonstrated that it covered the entire Ipg35-8 open reading frame and contained moreover app. 100 to 200 bp of downstream sequence and app. 3.5 kb of upstream sequence. The DNA sequence of a stretch of about 2.3 kb (including the promoter, the 5' untranslated region and the first 24 nucleotides of the open reading frame) was determined and is presented in SEQ ID No 13.<!-- EPO <DP n="37"> --></p>
<p id="p0107" num="0107">In view of the fact that the cDNA clone (SEQ ID No 1) and the genomic clone (SEQ ID No 13) were isolated from different <i>B. napus</i> cultivars (resp. cv.Topaz and cv.Bridger), it was surprisingly found that upon alignment of both sequences the overlapping fragment displayed 100 % sequence identity.</p>
<p id="p0108" num="0108">The transcription start site of the DZ selective gene corresponding to the gene contained in the 6.3Sal clone is determined using generally known techniques such as primer extension analysis [Sambrook et al. (1989) <i>Molecular Cloning: A Laboratory Manual,</i> Second Edition, Cold Spring Harbor Laboratory Press, NY] or RACE-PCR [Innis et al. (1990) <i>PCR Protocols: A Guide to Methods and Applications,</i> Academic Press Inc.]. The 5'UTL is thought to be located between positions 2,219 and 2,227 of SEQ ID No 13.</p>
<p id="p0109" num="0109">Using well-established site-directed mutagenesis techniques [Ausubel et al. (1994), <i>supra</i>], the DNA sequence is modified to create a unique restriction enzyme (e.g., Ncol) recognition site around the ATG translation initiation codon of the coding sequence. This allows a straightforward fusion of the promoter region of the DZ-selective gene to a DNA sequence of interest to construct a DZ-selective chimeric gene of this invention. Using a unique restriction enzyme recognition site located between 500 to 2,000 base pairs upstream (i.e., 5') of the unique restriction site surrounding the ATG translation initiation codon, a well defined DNA fragment is isolated, that is subsequently used as a promoter cassette, hereinafter referred to as PDZ, that directs DZ-selective expression in plants.</p>
<p id="p0110" num="0110">For example, a SphI-Ncol fragment (of about 2.08 kb), which is capable of directing DZ-selective expression in plants, is then subsequently used as a promoter cassette, hereinafter referred to as PDZ1.</p>
<p id="p0111" num="0111">A DZ-selective chimeric gene (PDZ or PDZ1-gus-3'nos) is constructed comprising the following operably linked DNA fragments :
<ul id="ul0004" list-style="dash" compact="compact">
<li>PDZ or PDZ1 : the 5' regulatory region comprising a DZ-selective promoter,</li>
<li>gus : a DNA fragment coding for beta-glucuronidase [Jefferson et al. (1986)<!-- EPO <DP n="38"> --> <i>Proc. Natl. Acad. Sci. USA</i> <b>83</b>: 8447];</li>
<li>3'nos : the 3' untranslated end comprising the polyadenylation site of the nopaline synthase gene ("3'nos")[Depicker et al. (1982), J. Mol. Appl. Genet. <b>1</b>: 561].</li>
</ul></p>
<p id="p0112" num="0112">A second promoter cassette which is capable of directing DZ-selective expression in plants, was obtained using well-established site-directed mutagenesis techniques to modify the DNA sequence to create a unique restriction site immediately upstream of the ATG translation initiation codon of the coding sequence. For this purpose a <i>Sma</i>I site has been engineered, immediately upstream of the ATG-codon, by changing the A-nucleotides of SEQ ID No. 13 at positions 2327 and 2328 into G-nucleotides. The Sphl-Smal fragment of about 2.1 kb, hereinafter referred to as promoter cassette PDZ2, was fused at the <i>Sma</i>I site upstream of the GUS coding region in the plasmid pBI101 (Clontech Laboratories, Inc CA, USA), resulting in a plasmid (2.1guspgem7) carrying the chimeric PDZ2-<u style="single">gus</u>-3'nos gene construct.</p>
<p id="p0113" num="0113">A chimeric selectable marker gene PSSU-bar-3'ocs was constructed [De Almeida et al. (1989), <i>Mol. Gen. Genet.</i> <b>218</b>: 78]. It comprises the following operably linked DNA fragments:
<ul id="ul0005" list-style="dash" compact="compact">
<li>PSSU : the promoter region of <i>Arabidopsis thaliana</i> ribulose-1,5-biphosphate carboxylase small subunit 1A encoding gene [Krebbers et al. (1988), <i>Plant Mol. Biol.</i> <b>11</b>: 745),</li>
<li><u style="single">bar</u> : the region of the bar gene encoding phosphinothricin acetyl transferase[Thompson et al. (1987), <i>The EMBO J.</i> <b>6</b>: 2519],</li>
<li>3'ocs : a 3' untranslated end comprising the polyadenylation site of the octopine synthase gene [De Greve et al. (1983), <i>J. Mol. Appl. Genet.</i> <b>1</b>: 499].</li>
</ul></p>
<p id="p0114" num="0114">Alternatively, a PSSU-<u style="single">bar</u>-3'g7 was constructed comprising identical fragments as the preceeding chimeric selectable marker gene, except that the 3' ocs was replaced by the 3' untranslated end comprising the polyadenylation site of the T-DNA gene 7 (3'g7; Velten and Schell (1985), <i>Nucl. Acids Research,</i> <b>13</b>, 6981).<!-- EPO <DP n="39"> --></p>
<p id="p0115" num="0115">Both the DZ-selective chimeric gene (PDZ2-<u style="single">gus</u>-3'nos; cloned as a <i>Hind</i>III-<i>Xho</i>I fragment of about 4.2 kb) and the chimeric marker gene (PSSU-<u style="single">bar</u>-3'g7) were introduced into the polylinker located between the border sequences of the T-DNA vector pGSV5, resulting in plasmid vector pTCO155 carrying the PDZ2-gus-3'nos and pSsuAra-bar-3'g7 chimeric gene constructs between the T-DNA border repeats. pGSV5 was derived from plasmid pGSC1700 [Comelissen and Vandewiele (1989), <i>Nucl. Acids Res.</i> <b>17</b>: 833] but differs from the latter in that it does not contain a beta-lactamase gene and that its T-DNA is characterized by the sequence of SEQ ID No 12.</p>
<heading id="h0013"><b><u style="single">EXAMPLE 4</u></b></heading>
<heading id="h0014"><b><u style="single">Construction of a chimeric gene carrying the bamase coding region under control of the endo-PG promoter.</u></b></heading>
<p id="p0116" num="0116">A DZ-selective chimeric gene (PDZ-<u style="single">barnase</u>-3'nos or PDZ1-<u style="single">barnase</u>-3'nos or PDZ2-<u style="single">barnase</u>-3'nos) is constructed comprising the following operably linked DNA fragments:
<ul id="ul0006" list-style="dash" compact="compact">
<li>PDZ or PDZ1 or PDZ2: a 5' regulatory region of Example 3, comprising a DZ-selective promoter,</li>
<li><u style="single">barnase</u> : a DNA fragment coding for bamase of <i>Bacillus amyloliquefaciens</i> [Hartley (1988), <i>J. Mol. Biol.</i> <b>202</b>: 913],</li>
<li>3'nos</li>
</ul></p>
<p id="p0117" num="0117">Both the DZ-selective chimeric gene and the PSSU-<u style="single">bar</u>-3'g7or PSSU-<u style="single">bar-</u>3'ocs chimeric marker genes are introduced into the polylinker located between the border sequences of the T-DNA vector pGSV5 of Example 4.</p>
<p id="p0118" num="0118">PDZ2-barnase-3'nos between T-DNA border repeats was constructed by replacing the pTA29 promoter upstream of the bamase coding region in pTC099, by the PDZ2 promoter cassette. To this end the 2.1 kb (blunted) <i>Sph</i>I<i>-Sma</i>I<!-- EPO <DP n="40"> --> fragment comprising PDZ2 was fused with its <i>Sma</i>I site to the blunted Ncol site overlapping with the ATG-codon which had been engineered at the 5' end of the coding sequence for the mature bamase in pTCO99, resulting in the plasmid vector pTPR1 carrying the PDZ2-<u style="single">barnase</u>-3'nos chimeric gene between the T-DNA border repeats. The T-DNA vector part of pTC099 is derived from that of pGSV5 by insertion of an <i>Eco</i>RI linker (GGAATTCC) into <i>the Smal</i> site of the polylinker, and a <i>Bgl</i>II linker (CAGATCTG) into the <i>Nco</i>I site of the polylinker followed by introduction of the chimeric pTA29-<u style="single">barnase</u>-3'nos gene of pTCO113 [WO96/26283] into the <i>Eco</i>RI site of the polylinker. Introduction of the chimeric selectable marker gene pSSUAra-<u style="single">bar</u>-3'g7 in the polylinker sequence of pTPR1 between the T-DNA border repeats results in pTPR3.</p>
<p id="p0119" num="0119">An additional T-DNA vector (pTPR2) is constructed wherein the DZ-selective chimeric gene described above (PDZ2-<u style="single">barnase</u>-3'nos) is accompagnied by the <i>Bgl</i>II fragment of pTCO113 [WO96/26283] comprising the barstar coding region under control of nopaline synthase promoter (pnos-<u style="single">barstar-</u>3'g7) inserted into the polylinker of pTPR1 between the T-DNA border repeats. Introduction of the chimeric selectable marker gene pSSUAra-<u style="single">bar</u>-3'g7 in the polylinker sequence of pTPR2 between the T-DNA border repeats results in pTPR4.</p>
<heading id="h0015"><b><u style="single">EXAMPLE 5</u></b></heading>
<heading id="h0016"><b><u style="single">Construction of a DZ-selective chimeric gene encoding T-DNA gene 1 product or the rolB gene product.</u></b></heading>
<p id="p0120" num="0120">A DZ-selective chimeric gene (PDZ-<u style="single">g1</u>-3'nos) is constructed comprising the following operably linked DNA fragments:
<ul id="ul0007" list-style="dash" compact="compact">
<li>PDZ or PDZ1 orPDZ2 : a 5' regulatory region of Example 3; comprising a DZ-selective promoter,</li>
<li><u style="single">g1</u>: a DNA fragment encoding the Agrobacterium tumefaciens tryptophan 2-monooxygenase <i>(iaaM</i> or T-DNA gene 1 product)[Gielen et al. (1984),<!-- EPO <DP n="41"> --> <i>EMBO J..</i> <b>3</b>: 835], obtained by polymerase chain reaction using appropriately designed primers comprising sequences respectively identical and complementary to the sequences immediately flanking gene 1.</li>
<li>3'nos</li>
</ul></p>
<p id="p0121" num="0121">A second DZ-selective chimeric gene (PDZ-<u style="single">g2</u>-3'nos) is constructed comprising the following operably linked DNA fragments :
<ul id="ul0008" list-style="dash" compact="compact">
<li>PDZ or PDZ1 orPDZ2 : a 5' regulatory region of Example 3 comprising a DZ-selective promoter,</li>
<li><u style="single">g2</u> : a DNA fragment encoding the <i>Agrobacterium tumefaciens</i> indole-3-acetamide hydrolase (iaaH or T-DNA gene 2 product)[Gielen et al. (1984), <i>EMBO J.</i> <b>3</b>: 835], obtained by polymerase chain reaction amplification, using appropriately designed primers comprising sequences respectively identical and complementary to the sequences immediately flanking gene 2.</li>
<li>3'nos</li>
</ul></p>
<p id="p0122" num="0122">Both the DZ-selective chimeric gene (either PDZ-<u style="single">g1</u>-3'nos alone or in combination with PDZ-<u style="single">g2</u>-3'nos) and the PSSU-<u style="single">bar</u>-3'ocs or PSSU-<u style="single">bar</u>-3'g7 chimeric marker gene are introduced into the polylinker located between the border sequences of the T-DNA vector pGSV5 of Example 4.</p>
<p id="p0123" num="0123">Another DZ-selective chimeric gene (PDZ-<i>rolB</i>-3'nos) is constructed comprising the following operably linked DNA fragments :
<ul id="ul0009" list-style="dash" compact="compact">
<li>PDZ: the 5' regulatory region of Example 3, comprising a DZ-selective promoter,</li>
<li><i>rolB</i> : the open reading frame of the <i>Agrobacterium rhizogenes rolB</i> gene [Fumer et al. (1986), <i>Nature</i> <b>319</b>: 422]</li>
<li>3'nos</li>
</ul><!-- EPO <DP n="42"> --></p>
<p id="p0124" num="0124">Both the DZ-selective chimeric gene and the PSSU-<u style="single">bar</u>-3'ocs or the PSSU-<u style="single">bar</u>-3'g7 chimeric marker gene are introduced into the polylinker located between the border sequences of the T-DNA vector pGSV5 of Example 4.</p>
<heading id="h0017"><b><u style="single">EXAMPLE 6</u></b></heading>
<heading id="h0018"><b><u style="single">Construction of a DZ-selective chimeric gene encoding a mutant ETR1-1 ethylene receptor.</u></b></heading>
<p id="p0125" num="0125">A DZ-selective chimeric gene (PDZ-<u style="single">etr1-</u>1-3 nos) is constructed comprising the following operably linked DNA fragments :
<ul id="ul0010" list-style="dash" compact="compact">
<li>PDZ or PDZ1 or PDZ2 : a 5' regulatory region of Example 3, comprising a DZ-selective promoter,</li>
<li><i>etr1-1</i>: the open reading frame of the dominant, ethylene-insensitive mutant allele of the <i>Arabidopsis thaliana ETR</i> gene [Chang et al. (1993), <i>Science</i> <b>262</b>:239], isolated as a 2.7 kb fragment comprising the exons of the coding sequence separated by 5 introns obtained by PCR amplification using the plasmid carrying the 7.3 kb genomic <i>Eco</i>RI fragment comprising the DNA of the mutant <i>etr1</i> allele [Chang et al. (1993), <i>Science</i> <b>262</b>: 539] and appropriately designed primers.</li>
<li>3'nos</li>
</ul></p>
<p id="p0126" num="0126">Both the DZ-selective chimeric gene and the PSSU-<u style="single">bar</u>-3'ocs or PSSU-<u style="single">bar</u>-3'g7 chimeric marker gene are introduced into the polylinker located between the border sequences of the T-DNA vector pGSV5 of Example 4.</p>
<heading id="h0019"><b><u style="single">EXAMPLE 7</u></b></heading>
<heading id="h0020"><b><u style="single">Construction of a DZ-selective chimeric gene encoding antisense RNA complementary to mRNA from which the cDNA of SEQ ID No 1 can be prepared.</u></b></heading><!-- EPO <DP n="43"> -->
<p id="p0127" num="0127">A DZ-selective chimeric gene (PDZ-<u style="single">anti-PG-1</u>-3'nos) was constructed comprising the following operably linked DNA fragments :
<ul id="ul0011" list-style="dash" compact="compact">
<li>PDZ or PDZ1 or PDZ2 : a 5' regulatory region of Example 3, comprising a DZ-selective promoter,</li>
<li><i>anti-PG-1 :</i> a DNA fragment encoding an RNA which is complementary to the RNA encoded by the region of SEQ ID No 1 between nucleotide positions 10 and 1600.</li>
<li>3'nos</li>
</ul></p>
<p id="p0128" num="0128">To this end the CaMV35S promoter of the 35S-antisense PG construct comprising a DNA sequence complementary to the complete sequence of SEQ ID No 1 cloned between a CaMV 35S promoter and a polyadenylation signal (as described below) was eliminated by digetion with <i>Hinc</i>II and <i>Xho</i>I, and replaced by the fragment comprising PDZ2.</p>
<p id="p0129" num="0129">Both the DZ-selective chimeric gene and the PSSU-<u style="single">bar</u>-3'g7 or PSSU-<u style="single">bar</u> 3'ocs chimeric marker genes are introduced into the polylinker located between the border sequences of the T-DNA vector pGSV5 of Example 4.</p>
<p id="p0130" num="0130">Another DZ-selective chimeric gene (PDZ-<u style="single">anti-PG-2</u>-3'nos) is constructed comprising the following operably linked DNA fragments :
<ul id="ul0012" list-style="dash" compact="compact">
<li>PDZ or PDZ1 or PDZ2 : a 5' regulatory region of Example 3, comprising a DZ-selective promoter,</li>
<li><u style="single">anti-PG-2</u> : a DNA fragment encoding an RNA which is complementary to the RNA encoded by the region of SEQ ID No 1 between nucleotide positions 20 and 700.</li>
<li>3'nos</li>
</ul></p>
<p id="p0131" num="0131">Both the DZ-selective chimeric gene and the PSSU-<u style="single">bar</u>-3'ocs or the PSSU-<u style="single">bar</u>-3'g7 chimeric marker gene are introduced into the polylinker located between the border sequences of the T-DNA vector pGSV5 of Example 4.<!-- EPO <DP n="44"> --></p>
<p id="p0132" num="0132">Still another DZ-selective chimeric gene (PDZ-<u style="single">anti-PG-3</u>-3'nos) is constructed comprising the following operably linked DNA fragments :
<ul id="ul0013" list-style="dash" compact="compact">
<li>PDZ or PDZ1 or PDZ2 : the 5' regulatory region of Example 3, comprising a DZ-selective promoter,</li>
<li><u style="single">anti-PG-3</u> : a DNA fragment encoding an RNA which is complementary to the RNA encoded by the region of SEQ ID No 1 between nucleotide positions 800 and 1600.</li>
<li>3'nos</li>
</ul></p>
<p id="p0133" num="0133">Both the DZ-selective chimeric gene and the PSSU-<u style="single">bar</u>-3'ocs or the PSSU-<u style="single">bar</u>-3'g7 chimeric marker gene are introduced into the polylinker located between the border sequences of the T-DNA vector pGSV5 of Example 4.</p>
<p id="p0134" num="0134">Three other antisense constructs were constructed comprising a CaMV 35S promoter, a DNA sequence complementary to the complete sequence of SEQ ID No1, or a DNA sequence complementary to 679 bp of the 3' end of SEQ ID No 1 (A67), or a DNA sequence complementary to 336 bp of the 3' end of SEQ ID No 1 (A30), and a polyadenylation signal. The cDNA of cDNA-library clone X was excised as a <i>EcoR</i>I<i>-Xhol</i> fragment and inserted in pBluescript® (Stratagene, CA USA). The full length cDNA was isolated as a <i>Bam</i>HI<i>-Xho</i>I fragment from this plasmid and inserted into <i>Bam</i>HI-<i>Xho</i>I digested pRT100 vector [Topfer et al (1987) <i>Nucleic Acids Research</i> <b>15</b>, 5890], between the CaMV35S promoter and polyadenylation signal. The resulting plasmid was digested with <i>BamHI</i> and <i>Eco</i>Rl, treated with Klenow polymerase and self-ligated.</p>
<p id="p0135" num="0135">The <i>Hae</i>III-<i>Xho</i>I fragment of the pBluescript® plasmid with the cDNA insert comprising the 3' end 679 bp of SEQ ID No 1 was inserted into the Smal-<i>Xho</i>I digested pRT100 vector, between the CaMV35S promoter and polyadenylation signal, resulting in plasmid A67.</p>
<p id="p0136" num="0136">The A 67 construct was digested with <i>Xba</i>I and <i>Sty</i>l, treated with Klenow polymerase and self-ligated, resulting in plasmid A30, comprising the DNA sequence complementary to 336 bp of the 3' end of SEQ ID No 1 between the<!-- EPO <DP n="45"> --> CaMV35S promoter and polyadenylation signal. The chimeric genes were isolated as <u style="single">Pst</u>l fragments.</p>
<p id="p0137" num="0137">35S-antisense-PG chimeric genes and the PSSU-<u style="single">bar</u>-3'ocs or the PSSU-<u style="single">bar</u>-3'g7 chimeric marker gene are introduced into the polylinker located between the border sequences of the T-DNA vector pGSV5 of Example 4.</p>
<heading id="h0021"><b><u style="single">EXAMPLE 8</u></b></heading>
<heading id="h0022"><b><u style="single">Transformation of oilseed rape and characterization of the transformants.</u> <i>Agrobacterium</i>-mediated transformation.</b></heading>
<p id="p0138" num="0138">Hypocotyl explants of <i>Brassica napus</i> are obtained, cultured and transformed essentially as described by De Block et al. ((1989), <i>Plant Physiol.</i> <b>91</b>: 694), except for the following modifications:
<ul id="ul0014" list-style="dash" compact="compact">
<li>hypocotyl explants are precultured for 3 days in A2 medium [MS, 0.5 g/l Mes (pH5.7), 1.2% glucose, 0.5% agarose, 1 mg/l 2,4-D, 0.25 mg/l naphthalene acetic acid (NAA)and 1 mg/l 6-benzytaminopurine (BAP)].</li>
<li>infection medium A3 is MS, 0.5 g/l Mes (pH5.7), 1.2% glucose, 0.1 mg/l NAA, 0.75 mg/l BAP and 0.01 mg/l gibberellinic acid (GA3).</li>
<li>selection medium A5 is MS, 0.5 g/l Mes (pH5.7), 1.2% glucose, 40 mg/l adenine.SO<sub>4</sub>, 0.5 g/l polyvinylpyrrolidone (PVP), 0.5% agarose, 0.1 mg/l NAA,<br/>
0.75 mg/l BAP, 0.01 mg/l GA3, 250 mg/l carbenicillin, 250 mg/l triacillin, 0.5 mg/l AgNO<sub>3</sub>.</li>
<li>regeneration medium A6 is MS, 0.5 g/l Mes (pH5.7), 2% sucrose, 40 mg/l adenine.SO<sub>4</sub>, 0.5 g/l PVP, 0.5% agarose, 0.0025mg/l BAP and 250 mg/l triacillin.</li>
<li>healthy shoots are transferred to rooting medium which was A8: 100-130 ml half concentrated MS, 1% sucrose (pH5.0), 1 mg/l isobutyric acid (IBA), 100 mg/l triacillin added to 300 ml perlite (final pH6.2) in 1 liter vessels.<!-- EPO <DP n="46"> --> MS stands for Murashige and Skoog medium [Murashige and Skoog (1962), <i>Physiol. Plant.</i> <b>15</b>: 473).</li>
</ul></p>
<p id="p0139" num="0139">Hypocotyl explants are infected with <i>Agrobacterium tumefaciens</i> strain C58C1RifR carrying :
<ul id="ul0015" list-style="dash" compact="compact">
<li>a helper Ti-plasmid such as pGV4000 which is a derivative of pMP90 [Koncz and Schell (1986), <i>Mol. Gen. Genet.</i> <b>204</b>: 383) obtained by insertion of a bacterial chloramphenicol resistance gene linked to a 2.5 kb fragment having homology with the T-DNA vector pGSV5, into pMP90.</li>
<li>T-DNA vector derived from pGSV5 comprising between the T-DNA borders the DZ-selective chimeric gene of Example 3, 4, 5, 6, or 7 and the chimeric marker gene.</li>
</ul></p>
<p id="p0140" num="0140">Selected lines from these transformants harboring one type of the chimeric genes of the invention are further used for crossing experiments, yielding new lines comprising combinations of the chimeric genes of the invention.</p>
<heading id="h0023"><b><u style="single">Characterization of transformants.</u></b></heading>
<p id="p0141" num="0141">Transformed <i>Brassica napus</i> plants of Example 8, comprising in their nuclear genomes the DZ-selective chimeric gene of Example 3, were in various tissues of the plants using conventional in-situ histochemical techniques [De Block and Debrouwer (1992), <i>The Plant Journal</i> <b>2:261;</b> De Block and Debrouwer (1993), <i>Planta</i> <b>189:</b> 218]. High GUS activity was found in the DZ layer of the pods, as reflected by the strong staining, while no background labelling was observed in other pod tissues, attesting to the fact that the promoter of Example 3 directs expression selectively in the pod DZ.</p>
<p id="p0142" num="0142">Transformed <i>Brassica napus</i> plants of Example 8, comprising in their nuclear genomes the DZ-selective chimeric genes of Example 4, 5, 6 or 7 alone or in combination are characterized with respect to the following characteristics:<!-- EPO <DP n="47"> -->
<ol id="ol0004" ol-style="">
<li>1) changes in physiological processes by analysing diminution of expression of targetted gene products (such as cell wall hydrolases) or diminution in the biochemical activities (See Blumenkratz, <i>supra</i>), by monitoring the heterologous gene expression (See, Sambrook et al <i>supra</i>), or by measuring the endogenous levels of IAA and IAA conjugates during development (See, Example 1)</li>
<li>2) changes in DZ anatomy and DZ cell walls during pod senescence by light microscopy and transmission electron microscopy; the extent of cell separation after pod opening by analysing seperated DZ surfaces with the scanning electron microscope (See, Example 1)</li>
<li>3) changes in the mechanical properties of the DZ and their seed shatter resistance by analysing the shatter resistance of individual pods. This can be done by the cantilever test as described by Kadkol et al. [(1986), <i>Aust. J. Bot.</i> <b>34:</b> 595]. Clamped pods are loaded as a cantilever in a "universal testing machine", consisting of a cross-head beam moved by actuators to which a load cell applies a constant force to deflect the pod. This records the displacement and the force necessary to initiate and propagate an opening in the pod dehiscence zone.. Alternatively, a first assessment of shatter susceptibility is carried out with detached pods subjected to controlled vibration (simulating impact with the canopy and machinery). The vibration consists of horizontal oscillation of fixed amplitude in a container with steel balls to enhance energy transfer. In yet another procedure, susceptibility to crack propagation is determined by friction measurement. In this case, the force generated due to friction between a wedge forced along the DZ is recorded and enables comparison of DZ tissues in selected, extreme examples of resistance.</li>
</ol></p>
<p id="p0143" num="0143">Finally, individual selected lines are subjected to per se performance analysis in the field. The design of these field trials is based on the cultivation of individual lines (homozygous for the transgene) at two locations in three replicates.<!-- EPO <DP n="48"> --></p>
<p id="p0144" num="0144">Analysis of a statistically significant number of pods from different transformed plants demonstrates an increase in pod shatter resistance when compared to untransformed control plants.</p>
<p id="p0145" num="0145">Needless to say, the use of the DZ-selective promoter and recombinant DNA constructs of this invention is not limited to the transformation of the specific plant of the examples. Such promoter and recombinant DNA constructs can be useful in transforming any crop, where the promoter can drive gene expression, preferably where such expression is to occur abundantly in the plant cells of the dehiscence zone.</p>
<p id="p0146" num="0146">Also, the use of the DZ-selective promoter of the present invention is not limited to the control of particular transcribed DNA regions of the invention, but can be used to control expression of any foreign gene or DNA fragment in a plant.<!-- EPO <DP n="49"> --></p>
<heading id="h0024">SEQUENCE LISTING</heading>
<p id="p0147" num="0147">
<ol id="ol0005" compact="compact" ol-style="">
<li>(1) GENERAL INFORMATION:
<ul id="ul0016" list-style="none">
<li>(i) APPLICANT:
<ul id="ul0017" list-style="none" compact="compact">
<li>(A) NAME: Plant Genetic Systems N.V.</li>
<li>(B) STREET: Jozef Plateaustraat 22</li>
<li>(C) CITY: Gent</li>
<li>(E) COUNTRY: Belgium</li>
<li>(F) POSTAL CODE (ZIP): B-9000</li>
<li>(G) TELEPHONE: 32 9 235 84 54</li>
<li>(H) TELEFAX: 32 9 223 19 23</li>
</ul></li>
<li>(ii) TITLE OF INVENTION: Seed shattering</li>
<li>(iii) NUMBER OF SEQUENCES: 13</li>
<li>(iv) COMPUTER READABLE FORM:
<ul id="ul0018" list-style="none" compact="compact">
<li>(A) MEDIUM TYPE: Floppy disk</li>
<li>(B) COMPUTER: IBM PC compatible</li>
<li>(C) OPERATING SYSTEM: PC-DOS/MS-DOS</li>
<li>(D) SOFTWARE: PatentIn Release #1.0, Version #1.30 (EPO)</li>
</ul></li>
<li>(v) CURRENT APPLICATION DATA:
<ul id="ul0019" list-style="none" compact="compact">
<li>APPLICATION NUMBER: EP 95203328.0</li>
</ul></li>
</ul></li>
<li>(2) INFORMATION FOR SEQ ID NO: 1:
<ul id="ul0020" list-style="none">
<li>(i) SEQUENCE CHARACTERISTICS:
<ul id="ul0021" list-style="none" compact="compact">
<li>(A) LENGTH: 1631 base pairs</li>
<li>(B) TYPE: nucleic acid</li>
<li>(C) STRANDEDNESS: double</li>
<li>(D) TOPOLOGY: linear</li>
</ul></li>
<li>(ii) MOLECULE TYPE: cDNA to mRNA</li>
<li>(iii) HYPOTHETICAL: NO</li>
<li>(iv) ANTI-SENSE: NO</li>
<li>(vi) ORIGINAL SOURCE:
<ul id="ul0022" list-style="none" compact="compact">
<li>(A) ORGANISM: Brassica napus</li>
<li>(B) STRAIN: cv. Topaz</li>
</ul></li>
<li>(ix) FEATURE:
<ul id="ul0023" list-style="none" compact="compact">
<li>(A) NAME/KEY: CDS</li>
<li>(B) LOCATION:95..1393</li>
</ul></li>
<li>(ix) FEATURE:
<ul id="ul0024" list-style="none" compact="compact">
<li>(A) NAME/KEY: -</li>
<li>(B) LOCATION:821..837</li>
<li>(D) OTHER INFORMATION:/label= PG1<br/>
/note= "region of endo-PG cDNA corresponding to oligonucleotide PG1"</li>
</ul></li>
<li>(ix) FEATURE:
<ul id="ul0025" list-style="none" compact="compact">
<li>(A) NAME/KEY: -</li>
<li>(B) LOCATION:95..163</li>
<li>(D) OTHER INFORMATION:/label= SP<br/>
/note= "region encoding the presumed endo-PG signal peptide"</li>
</ul></li>
<li>(ix) FEATURE:
<ul id="ul0026" list-style="none" compact="compact">
<li>(A) NAME/KEY: -</li>
<li>(B) LOCATION:884..900</li>
<li>(D) OTHER INFORMATION:/label= PG3<br/>
/note= "region of the endo-PG cDNA corresponding to oligonucleotide PG3"</li>
</ul></li>
<li>(ix) FEATURE:
<ul id="ul0027" list-style="none" compact="compact">
<li>(A) NAME/KEY: -</li>
<li>(B) LOCATION:1059..1073</li>
<li>(D) OTHER INFORMATION:/label= PG2<br/>
/note= "region of the endo-PG cDNA complementary to oligonucleotide PG2"</li>
</ul><!-- EPO <DP n="50"> --></li>
<li>(ix) FEATURE:
<ul id="ul0028" list-style="none" compact="compact">
<li>(A) NAME/KEY: -</li>
<li>(B) LOCATION:1229..1245</li>
<li>(D) OTHER INFORMATION:/label= PG5<br/>
/note= "region of the endo-PG cDNA complementary to oligonucleotide PG5"</li>
</ul></li>
<li>(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 1:
<img id="ib0001" file="imgb0001.tif" wi="164" he="179" img-content="dna" img-format="tif"/></li>
</ul></li>
<li>(2) INFORMATION FOR SEQ ID NO: 2:
<ul id="ul0029" list-style="none">
<li>(i) SEQUENCE CHARACTERISTICS:
<ul id="ul0030" list-style="none" compact="compact">
<li>(A) LENGTH: 27 base pairs</li>
<li>(B) TYPE: nucleic acid</li>
<li>(C) STRANDEDNESS: single</li>
<li>(D) TOPOLOGY: linear</li>
</ul></li>
<li>(ii) MOLECULE TYPE: other nucleic acid<!-- EPO <DP n="51"> -->
<ul id="ul0031" list-style="none" compact="compact">
<li>(A) DESCRIPTION: /desc = "oligonucleotide PG1"</li>
</ul></li>
<li>(iii) HYPOTHETICAL: NO</li>
<li>(iv) ANTI-SENSE: NO</li>
<li>(ix) FEATURE:
<ul id="ul0032" list-style="none" compact="compact">
<li>(A) NAME/KEY: modified_base</li>
<li>(B) LOCATION:16</li>
<li>(D) OTHER INFORMATION:/mod base= i<br/>
/note= "N at residue position 16 represents the neutral base inosine"</li>
</ul></li>
<li>(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 2:
<ul id="ul0033" list-style="none" compact="compact">
<li>CCAGGAATTC AAYACNGAYG GNRTNCA    27</li>
</ul></li>
</ul></li>
<li>(2) INFORMATION FOR SEQ ID NO: 3:
<ul id="ul0034" list-style="none">
<li>(i) SEQUENCE CHARACTERISTICS:
<ul id="ul0035" list-style="none" compact="compact">
<li>(A) LENGTH: 25 base pairs</li>
<li>(B) TYPE: nucleic acid</li>
<li>(C) STRANDEDNESS: single</li>
<li>(D) TOPOLOGY: linear</li>
</ul></li>
<li>(ii) MOLECULE TYPE: other nucleic acid
<ul id="ul0036" list-style="none" compact="compact">
<li>(A) DESCRIPTION: /desc = "oligonucleotide PG2"</li>
</ul></li>
<li>(iii) HYPOTHETICAL: NO</li>
<li>(iv) ANTI-SENSE: NO</li>
<li>(ix) FEATURE:
<ul id="ul0037" list-style="none" compact="compact">
<li>(A) NAME/KEY: modified_base</li>
<li>(B) LOCATION:12</li>
<li>(D) OTHER INFORMATION:/mod base= i<br/>
/note= "N at residue position 12 represents the neutral base Inosine"</li>
</ul></li>
<li>(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 3:
<ul id="ul0038" list-style="none" compact="compact">
<li>CGACGGATCC ANGTYTTDAT NCKNA    25</li>
</ul></li>
</ul></li>
<li>(2) INFORMATION FOR SEQ ID NO: 4:
<ul id="ul0039" list-style="none">
<li>(i) SEQUENCE CHARACTERISTICS:
<ul id="ul0040" list-style="none" compact="compact">
<li>(A) LENGTH: 27 base pairs</li>
<li>(B) TYPE: nucleic acid</li>
<li>(C) STRANDEDNESS: single</li>
<li>(D) TOPOLOGY: linear</li>
</ul></li>
<li>(ii) MOLECULE TYPE: other nucleic acid
<ul id="ul0041" list-style="none" compact="compact">
<li>(A) DESCRIPTION: /desc = "oligonucleotide PG3"</li>
</ul></li>
<li>(iii) HYPOTHETICAL: NO</li>
<li>(iv) ANTI-SENSE: NO</li>
<li>(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 4:
<ul id="ul0042" list-style="none" compact="compact">
<li>GGACGAATTC ACNGGNGAYG AYTGYAT    27</li>
</ul></li>
</ul></li>
<li>(2) INFORMATION FOR SEQ ID NO: 5:
<ul id="ul0043" list-style="none">
<li>(i) SEQUENCE CHARACTERISTICS:
<ul id="ul0044" list-style="none" compact="compact">
<li>(A) LENGTH: 27 base pairs</li>
<li>(B) TYPE: nucleic acid</li>
<li>(C) STRANDEDNESS: single<!-- EPO <DP n="52"> --></li>
<li>(D) TOPOLOGY: linear</li>
</ul></li>
<li>(ii) MOLECULE TYPE: other nucleic acid
<ul id="ul0045" list-style="none" compact="compact">
<li>(A) DESCRIPTION: /desc = "oligonucleotide PG5"</li>
</ul></li>
<li>(iii) HYPOTHETICAL: NO</li>
<li>(iv) ANTI-SENSE: NO</li>
<li>(ix) FEATURE:
<ul id="ul0046" list-style="none" compact="compact">
<li>(A) NAME/KEY: modified_base</li>
<li>(B) LOCATION:13</li>
<li>(D) OTHER INFORMATION:/mod base= i<br/>
/note= "N at residue position 13 represents inosine"</li>
</ul></li>
<li>(ix) FEATURE:
<ul id="ul0047" list-style="none" compact="compact">
<li>(A) NAME/KEY: modified_base</li>
<li>(B) LOCATION:16</li>
<li>(D) OTHER INFORMATION:/mod base= i<br/>
/note= "N at residue position 16 represents inosine"</li>
</ul></li>
<li>(ix) FEATURE:
<ul id="ul0048" list-style="none" compact="compact">
<li>(A) NAME/KEY: modified_base</li>
<li>(B) LOCATION:19</li>
<li>(D) OTHER INFORMATION:/mod base= i<br/>
/note= "N at residue position 19 represents inosine"</li>
</ul></li>
<li>(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 5:
<ul id="ul0049" list-style="none" compact="compact">
<li>CACAGGATCC SWNGTNCCNY KDATRTT    27</li>
</ul></li>
</ul></li>
<li>(2) INFORMATION FOR SEQ ID NO: 6:
<ul id="ul0050" list-style="none">
<li>(i) SEQUENCE CHARACTERISTICS:
<ul id="ul0051" list-style="none">
<li>(A) LENGTH: 155 base pairs</li>
<li>(B) TYPE: nucleic acid</li>
<li>(C) STRANDEDNESS: double</li>
<li>(D) TOPOLOGY: linear</li>
</ul></li>
<li>(ii) MOLECULE TYPE: other nucleic acid
<ul id="ul0052" list-style="none" compact="compact">
<li>(A) DESCRIPTION: /desc = "PCR fragment BPG32-26 from first strand cDNA"</li>
</ul></li>
<li>(iii) HYPOTHETICAL: NO</li>
<li>(iv) ANTI-SENSE: NO</li>
<li>(vi) ORIGINAL SOURCE:
<ul id="ul0053" list-style="none" compact="compact">
<li>(A) ORGANISM: Brassica napus</li>
<li>(B) STRAIN: cv. Topaz</li>
</ul></li>
<li>(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 6:
<img id="ib0002" file="imgb0002.tif" wi="165" he="19" img-content="dna" img-format="tif"/></li>
</ul></li>
<li>(2) INFORMATION FOR SEQ ID NO: 7:
<ul id="ul0054" list-style="none">
<li>(i) SEQUENCE CHARACTERISTICS:
<ul id="ul0055" list-style="none">
<li>(A) LENGTH: 155 base pairs</li>
<li>(B) TYPE: nucleic acid</li>
<li>(C) STRANDEDNESS: double</li>
<li>(D) TOPOLOGY: linear</li>
</ul></li>
<li>(ii) MOLECULE TYPE: other nucleic acid
<ul id="ul0056" list-style="none" compact="compact">
<li>(A) DESCRIPTION: /desc = "PCR fragment KPG32-8 from first strand cDNA"</li>
</ul><!-- EPO <DP n="53"> --></li>
<li>(iii) HYPOTHETICAL: NO</li>
<li>(iv) ANTI-SENSE: NO</li>
<li>(vi) ORIGINAL SOURCE:
<ul id="ul0057" list-style="none" compact="compact">
<li>(A) ORGANISM: Brassica napus</li>
<li>(B) STRAIN: cv. Topaz</li>
</ul></li>
<li>(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 7:
<img id="ib0003" file="imgb0003.tif" wi="165" he="20" img-content="dna" img-format="tif"/></li>
</ul></li>
<li>(2) INFORMATION FOR SEQ ID NO: 8:
<ul id="ul0058" list-style="none">
<li>(i) SEQUENCE CHARACTERISTICS:
<ul id="ul0059" list-style="none" compact="compact">
<li>(A) LENGTH: 219 base pairs</li>
<li>(B) TYPE: nucleic acid</li>
<li>(C) STRANDEDNESS: double</li>
<li>(D) TOPOLOGY: linear</li>
</ul></li>
<li>(ii) MOLECULE TYPE: other nucleic acid
<ul id="ul0060" list-style="none" compact="compact">
<li>(A) DESCRIPTION: /desc = "PCR fragment LPG12-16 from first strand cDNA"</li>
</ul></li>
<li>(iii) HYPOTHETICAL: NO</li>
<li>(iv) ANTI-SENSE: NO</li>
<li>(vi) ORIGINAL SOURCE:
<ul id="ul0061" list-style="none" compact="compact">
<li>(A) ORGANISM: Brassica napus</li>
<li>(B) STRAIN: cv. Topaz</li>
</ul></li>
<li>(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 8:
<img id="ib0004" file="imgb0004.tif" wi="164" he="25" img-content="dna" img-format="tif"/></li>
</ul></li>
<li>(2) INFORMATION FOR SEQ ID NO: 9:
<ul id="ul0062" list-style="none">
<li>(i) SEQUENCE CHARACTERISTICS:
<ul id="ul0063" list-style="none" compact="compact">
<li>(A) LENGTH: 155 base pairs</li>
<li>(B) TYPE: nucleic acid</li>
<li>(C) STRANDEDNESS: double</li>
<li>(D) TOPOLOGY: linear</li>
</ul></li>
<li>(ii) MOLECULE TYPE: other nucleic acid
<ul id="ul0064" list-style="none" compact="compact">
<li>(A) DESCRIPTION: /desc = "PCR fragment LPG32-24 from first strand cDNA"</li>
</ul></li>
<li>(iii) HYPOTHETICAL: NO</li>
<li>(iv) ANTI-SENSE: NO</li>
<li>(vi) ORIGINAL SOURCE:
<ul id="ul0065" list-style="none" compact="compact">
<li>(A) ORGANISM: Brassica napus</li>
<li>(B) STRAIN: cv. Topaz</li>
</ul></li>
<li>(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 9:
<img id="ib0005" file="imgb0005.tif" wi="165" he="12" img-content="dna" img-format="tif"/><!-- EPO <DP n="54"> -->
<img id="ib0006" file="imgb0006.tif" wi="165" he="14" img-content="dna" img-format="tif"/></li>
</ul></li>
<li>(2) INFORMATION FOR SEQ ID NO: 10:
<ul id="ul0066" list-style="none">
<li>(i) SEQUENCE CHARACTERISTICS:
<ul id="ul0067" list-style="none" compact="compact">
<li>(A) LENGTH: 155 base pairs</li>
<li>(B) TYPE: nucleic acid</li>
<li>(C) STRANDEDNESS: double</li>
<li>(D) TOPOLOGY: linear</li>
</ul></li>
<li>(ii) MOLECULE TYPE: other nucleic acid
<ul id="ul0068" list-style="none" compact="compact">
<li>(A) DESCRIPTION: /desc = "PCR fragment LPG32-25 from first strand cDNA"</li>
</ul></li>
<li>(iii) HYPOTHETICAL: NO</li>
<li>(iv) ANTI-SENSE: NO</li>
<li>(vi) ORIGINAL SOURCE:
<ul id="ul0069" list-style="none" compact="compact">
<li>(A) ORGANISM: Brassica napus</li>
<li>(B) STRAIN: cv. Topaz</li>
</ul></li>
<li>(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 10:
<img id="ib0007" file="imgb0007.tif" wi="165" he="19" img-content="dna" img-format="tif"/></li>
</ul></li>
<li>(2) INFORMATION FOR SEQ ID NO: 11:
<ul id="ul0070" list-style="none">
<li>(i) SEQUENCE CHARACTERISTICS:
<ul id="ul0071" list-style="none" compact="compact">
<li>(A) LENGTH: 155 base pairs</li>
<li>(B) TYPE: nucleic acid</li>
<li>(C) STRANDEDNESS: double</li>
<li>(D) TOPOLOGY: linear</li>
</ul></li>
<li>(ii) MOLECULE TYPE: other nucleic acid
<ul id="ul0072" list-style="none" compact="compact">
<li>(A) DESCRIPTION: /desc = "PCR fragment LPG32-32 from first strand cDNA"</li>
</ul></li>
<li>(iii) HYPOTHETICAL: NO</li>
<li>(iv) ANTI-SENSE: NO</li>
<li>(vi) ORIGINAL SOURCE:
<ul id="ul0073" list-style="none" compact="compact">
<li>(A) ORGANISM: Brassica napus</li>
<li>(B) STRAIN: cv. Topaz</li>
</ul></li>
<li>(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 11:
<img id="ib0008" file="imgb0008.tif" wi="165" he="18" img-content="dna" img-format="tif"/></li>
</ul></li>
<li>(2) INFORMATION FOR SEQ ID NO: 12:
<ul id="ul0074" list-style="none" compact="compact">
<li>(i) SEQUENCE CHARACTERISTICS:
<ul id="ul0075" list-style="none" compact="compact">
<li>(A) LENGTH: 100 base pairs</li>
<li>(B) TYPE: nucleic acid</li>
<li>(C) STRANDEDNESS: double</li>
<li>(D) TOPOLOGY: linear</li>
</ul></li>
<li>(ii) MOLECULE TYPE: other nucleic acid
<ul id="ul0076" list-style="none" compact="compact">
<li>(A) DESCRIPTION: /desc = "DNA sequence of the T-DNA of pGSVS"</li>
</ul><!-- EPO <DP n="55"> --></li>
<li>(iii) HYPOTHETICAL: NO</li>
<li>(iv) ANTI-SENSE: NO</li>
<li>(ix) FEATURE:
<ul id="ul0077" list-style="none" compact="compact">
<li>(A) NAME/KEY: -</li>
<li>(B) LOCATION:1..25</li>
<li>(D) OTHER INFORMATION:/label= RB<br/>
/note= "right border sequence from the T-DNA of pGSV5"</li>
</ul></li>
<li>(ix) FEATURE:
<ul id="ul0078" list-style="none" compact="compact">
<li>(A) NAME/KEY: -</li>
<li>(B) LOCATION:26..75</li>
<li>(D) OTHER INFORMATION:/label= MCS<br/>
/note= "Multiple Cloning Site"</li>
</ul></li>
<li>(ix) FEATURE:
<ul id="ul0079" list-style="none" compact="compact">
<li>(A) NAME/KEY: -</li>
<li>(B) LOCATION:76..100</li>
<li>(D) OTHER INFORMATION:/label= LB<br/>
/note= "left border sequence from the T-DNA of pGSV5"</li>
</ul></li>
<li>(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 12:
<img id="ib0009" file="imgb0009.tif" wi="165" he="13" img-content="dna" img-format="tif"/></li>
</ul></li>
<li>(2) INFORMATION FOR SEQ ID NO: 13:
<ul id="ul0080" list-style="none" compact="compact">
<li>(i) SEQUENCE CHARACTERISTICS:
<ul id="ul0081" list-style="none" compact="compact">
<li>(A) LENGTH: 2352 base pairs</li>
<li>(B) TYPE: nucleic acid</li>
<li>(C) STRANDEDNESS: double</li>
<li>(D) TOPOLOGY: linear</li>
</ul></li>
<li>(ii) MOLECULE TYPE: DNA (genomic)</li>
<li>(iii) HYPOTHETICAL: NO</li>
<li>(iv) ANTI-SENSE: NO</li>
<li>(vi) ORIGINAL SOURCE:
<ul id="ul0082" list-style="none" compact="compact">
<li>(A) ORGANISM: Brassica napus</li>
<li>(B) STRAIN: cv. Bridger</li>
</ul></li>
<li>(ix) FEATURE:
<ul id="ul0083" list-style="none" compact="compact">
<li>(A) NAME/KEY: -</li>
<li>(B) LOCATION:2329..2331</li>
<li>(D) OTHER INFORMATION:/label= ATG<br/>
/note= "translation initiation codon"</li>
</ul></li>
<li>(ix) FEATURE:
<ul id="ul0084" list-style="none" compact="compact">
<li>(A) NAME/KEY: -</li>
<li>(B) LOCATION:246..251</li>
<li>(D) OTHER INFORMATION:/label= SphI<br/>
/note= "SphI restriction enzyme recognition site"</li>
</ul></li>
<li>(ix) FEATURE:
<ul id="ul0085" list-style="none" compact="compact">
<li>(A) NAME/KEY: -</li>
<li>(B) LOCATION:1051..1056</li>
<li>(D) OTHER INFORMATION:/label= BamHI<br/>
/note= "BamHI restriction enzyme recognition site"</li>
</ul></li>
<li>(ix) FEATURE:
<ul id="ul0086" list-style="none" compact="compact">
<li>(A) NAME/KEY: -</li>
<li>(B) LOCATION:1836..1841</li>
<li>(D) OTHER INFORMATION:/label= HindII<br/>
/note= "HindII restriction enzyme recognition site"</li>
</ul></li>
<li>(ix) FEATURE:
<ul id="ul0087" list-style="none" compact="compact">
<li>(A) NAME/KEY: -</li>
<li>(B) LOCATION:2327..2332<!-- EPO <DP n="56"> --></li>
<li>(D) OTHER INFORMATION:/label= NcoI<br/>
/note= "sequence mutated to form a NcoI restriction enzyme recognition site (AAATGG changed to CCATGG)"</li>
</ul></li>
<li>(ix) FEATURE:
<ul id="ul0088" list-style="none" compact="compact">
<li>(A) NAME/KEY: -</li>
<li>(B) LOCATION:2219..2227</li>
<li>(D) OTHER INFORMATION:/label= transcript star<br/>
/note= "region containing the putative location of transcription<br/>
start site"</li>
</ul></li>
<li>(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 13:
<img id="ib0010" file="imgb0010.tif" wi="165" he="193" img-content="dna" img-format="tif"/><!-- EPO <DP n="57"> -->
<img id="ib0011" file="imgb0011.tif" wi="165" he="72" img-content="dna" img-format="tif"/></li>
</ul></li>
</ol></p>
</description><!-- EPO <DP n="58"> -->
<claims id="claims01" lang="en">
<claim id="c-en-01-0001" num="0001">
<claim-text>A plant comprising a pod dehiscence zone-selective chimeric gene incorporated in the nuclear genome of its cells, wherein said pod dehiscence zone-selective chimeric gene comprises the following operably linked DNA fragments:
<claim-text>a.) a transcribed DNA region encoding an RNA capable of inhibiting or reducing the expression of an endogenous plant gene encoding a cell wall hydrolase selectively expressed in cells of the pod dehiscence zone, said cell wall hydrolase comprising the amino acid sequence of the protein encoded by the nucleotide sequence of SEQ ID No 1 between the nucleotide at position 95 and the nucleotide at position 1393; and</claim-text>
<claim-text>b.) a plant expressible promoter which directs expression of said transcribed DNA region at least in said cells of said pod dehiscence zone,</claim-text>
wherein said plant is <b>characterized by</b> delayed pod dehiscence properties, when compared to a plant not containing said pod dehiscence zone-selective chimeric gene.</claim-text></claim>
<claim id="c-en-01-0002" num="0002">
<claim-text>The plant of claim 1, in which said transcribed DNA region encodes an antisense RNA which is directed to a sense RNA of said endogenous plant gene.</claim-text></claim>
<claim id="c-en-01-0003" num="0003">
<claim-text>The plant of claim 1, in which said transcribed DNA region encodes a ribozyme which is directed to a sense RNA of said endogenous plant gene.</claim-text></claim>
<claim id="c-en-01-0004" num="0004">
<claim-text>A plant comprising a pod dehiscence zone-selective chimeric gene incorporated in the nuclear genome of its cells, wherein said pod dehiscence zone-selective chimeric gene comprises the following operably linked DNA fragments:
<claim-text>a.) a transcribed DNA region encoding a protein or polypeptide, which when produced in said pod dehiscence zone cells, kills or disables them or interferes with their normal metabolism, physiology or development, selected from the group consisting of:
<claim-text>(1) a ribonuclease,</claim-text>
<claim-text>(2) a cytotoxin,</claim-text>
<claim-text>(3) tryptophan monooxygenase, indole-3-acetamide hydrolase, amidohydrolase,</claim-text>
<claim-text>(4) the product of the <i>rolB</i> gene, and</claim-text>
<claim-text>(5) a mutant ETR1 protein,</claim-text>
and</claim-text>
<claim-text>b.) a pod dehiscence zone-selective promoter comprising the nucleotide sequence of SEQ ID No 13 between positions 1,839 and 2,328,</claim-text>
wherein said plant is <b>characterized by</b> delayed pod dehiscence properties, when compared to a plant not containing said pod dehiscence zone-selective chimeric gene.<!-- EPO <DP n="59"> --></claim-text></claim>
<claim id="c-en-01-0005" num="0005">
<claim-text>The plant of claim 4, in which said transcribed DNA region encodes a ribonuclease, said plant further comprising integrated in its genome, a second chimeric gene comprising
<claim-text>a.) a second transcribed DNA region encoding an RNA, protein or polypeptide, which when expressed in non pod dehiscence zone cells, counteracts, prevents or inhibits the activity of the gene product of said pod dehiscence zone-selective chimeric gene; and</claim-text>
<claim-text>b.) a second plant expressible promoter, which directs expression of said second transcribed DNA region at least in said non pod dehiscence zone cells</claim-text>
wherein expression of said second chimeric gene prevents or inhibits the effects of low expression of said pod dehiscence zone-selective chimeric gene in said non pod dehiscence zone cells.</claim-text></claim>
<claim id="c-en-01-0006" num="0006">
<claim-text>The plant of claim 5, wherein said transcribed region from said pod dehiscence zone-selective chimeric gene encodes bamase, and wherein said second transcribed region encodes barstar.</claim-text></claim>
<claim id="c-en-01-0007" num="0007">
<claim-text>The plant of claim 5 or claim 6, wherein said plant expressible promoter which directs expression of said second transcribed DNA region is a nopaline synthase promoter or a CaMV35S minimal promoter.</claim-text></claim>
<claim id="c-en-01-0008" num="0008">
<claim-text>The plant of any one of claims 1 to 7, which is a <i>Brassica</i> species.</claim-text></claim>
<claim id="c-en-01-0009" num="0009">
<claim-text>The plant of any one of claims 1 to 3, in which said plant expressible promoter is a pod dehiscence zone-selective promoter.</claim-text></claim>
<claim id="c-en-01-0010" num="0010">
<claim-text>The plant of claim 9, in which said pod dehiscence zone-selective promoter comprises the nucleotide sequence of SEQ ID No 13 between positions 1,839 and 2,328.</claim-text></claim>
<claim id="c-en-01-0011" num="0011">
<claim-text>The plant of any one of claims 4 to 10, in which said a pod dehiscence zone-selective promoter comprises a fragment of about 661 nucleotides upstream from the nucleotide at position 2329 of SEQ ID No 13.</claim-text></claim>
<claim id="c-en-01-0012" num="0012">
<claim-text>The plant of any one of claims 4 to 11, in which said pod dehiscence zone-selective promoter comprises the nucleotide sequence of SEQ ID No 13 starting between position 251 and 1052 and ending at position 2,328.</claim-text></claim>
<claim id="c-en-01-0013" num="0013">
<claim-text>The plant of any one of claims 4 to 12, in which said pod dehiscence zone-selective promoter comprises the nucleotide sequence of SEQ ID No 13 between positions 1 and 2,328</claim-text></claim>
<claim id="c-en-01-0014" num="0014">
<claim-text>The plant of any one of claims 4 to 13, in which said pod dehiscence zone-selective promoter comprises a 5' untranslated leader sequence of another plant-expressible gene.<!-- EPO <DP n="60"> --></claim-text></claim>
<claim id="c-en-01-0015" num="0015">
<claim-text>A DNA comprising the nucleotide sequence of SEQ ID No 13 between positions 1,839 and 2,328.</claim-text></claim>
<claim id="c-en-01-0016" num="0016">
<claim-text>The DNA of claim 15 comprising a fragment of about 661 nucleotides upstream from the nucleotide at position 2329 of SEQ ID No 13.</claim-text></claim>
<claim id="c-en-01-0017" num="0017">
<claim-text>The DNA of claim 15 or 16, which comprises the nucleotide sequence of SEQ ID No 13 starting between position 251 and 1052 and ending at position 2,328.</claim-text></claim>
<claim id="c-en-01-0018" num="0018">
<claim-text>The DNA of any one of claims 15 to 17, which comprises the nucleotide sequence of SEQ ID No 13 between positions 1 and 2,328.</claim-text></claim>
<claim id="c-en-01-0019" num="0019">
<claim-text>A pod dehiscence zone-selective promoter comprising the DNA of any one of claims 15 to 18.</claim-text></claim>
<claim id="c-en-01-0020" num="0020">
<claim-text>The pod dehiscence zone-selective promoter of claim 19. comprising the 5' untranslated leader of another plant expressible gene.</claim-text></claim>
<claim id="c-en-01-0021" num="0021">
<claim-text>A pod dehiscence zone-selective chimeric gene as defined in any one of claims 1 to 14.</claim-text></claim>
<claim id="c-en-01-0022" num="0022">
<claim-text>A plant cell or plant cell culture transformed with the pod dehiscence zone-selective chimeric gene of claim 21.</claim-text></claim>
<claim id="c-en-01-0023" num="0023">
<claim-text>A seed of a plant containing the pod dehiscence zone-selective chimeric gene of claim 21, said seed comprising said pod dehiscence zone-selective chimeric gene.</claim-text></claim>
<claim id="c-en-01-0024" num="0024">
<claim-text>A method for producing a plant with delayed pod dehiscence properties, which comprises the steps of
<claim-text>a.) transforming the nuclear genome of a cell of a plant with the pod dehiscence zone-selective chimeric gene of claim 21 ; and</claim-text>
<claim-text>b.) regenerating a transformed plant from said transformed cell.</claim-text></claim-text></claim>
</claims><!-- EPO <DP n="61"> -->
<claims id="claims02" lang="de">
<claim id="c-de-01-0001" num="0001">
<claim-text>Pflanze, umfassend ein in das Zellkerngenom ihrer Zellen eingebautes chimäres, für die Schotendehiszenzzone selektives Gen, wobei dieses chimäre, für die Schotendehiszenzzone selektive Gen die folgenden operativ verbundenen DNA-Fragmente umfaßt:
<claim-text>a.) eine transkribierte DNA-Region, die für eine RNA codiert, die zur Hemmung oder Verringerung der Expression eines endogenen Pflanzengens, das für eine selektiv in Zellen der Schotendehiszenzzone exprimierten Zellwandhydrolase codiert, fähig ist, wobei diese Zellwandhydrolase die Aminosäuresequenz des von der Nukleotidsequenz gemäß SEQ ID Nr. 1 zwischen dem Nukleotid in Position 95 und dem Nukleotid in Position 1 393 codierten Proteins umfaßt; sowie</claim-text>
<claim-text>b.) einen in Pflanzen exprimierbaren Promoter, der die Expression dieser transkribierten DNA-Region zumindest in den Zellen der Schotendehiszenzzone steuert,</claim-text>
wobei diese Pflanze durch im Vergleich zu einer Pflanze, die dieses chimäre, für die Schotendehiszenzzone selektive Gen nicht enthält, durch<!-- EPO <DP n="62"> --> Eigenschaften einer verzögerten Schotendehiszenz <b>gekennzeichnet</b> ist.</claim-text></claim>
<claim id="c-de-01-0002" num="0002">
<claim-text>Pflanze nach Anspruch 1, in der die transkribierte DNA-Region für eine Antisense-RNA codiert, die gegen eine Sense-RNA des endogenen Pflanzengens gerichtet ist.</claim-text></claim>
<claim id="c-de-01-0003" num="0003">
<claim-text>Pflanze nach Anspruch 1, in der die transkribierte DNA-Region für ein Ribozym, das gegen eine Sense-RNA des endogenen Pflanzengens gerichtet ist, codiert.</claim-text></claim>
<claim id="c-de-01-0004" num="0004">
<claim-text>Pflanze, umfassend ein in das Zellkerngenom ihrer Zellen eingebautes chimäres, für die Schotendehiszenzzone selektives Gen, wobei dieses chimäre, für die Schotendehiszenzzone selektive Gen die folgenden operativ verbundenen DNA-Fragmente umfaßt:
<claim-text>a.) eine transkribierte DNA-Region, die für ein Protein oder Polypeptid codiert, das, wenn es in den Zellen der Schotendehiszenzzone produziert wird, diese abtötet oder unwirksam macht oder ihren normalen Metabolismus, ihre normale Physiologie oder ihre normale Entwicklung stört, ausgewählt aus der folgenden Gruppe:
<claim-text>(1) eine Ribonuklease,</claim-text>
<claim-text>(2) ein Cytotoxin,</claim-text>
<claim-text>(3) Tryptophanmonooxygenase, Indol-3-acetamidhydrolase, Amidohydrolase,</claim-text>
<claim-text>(4) das Produkt des <i>rolB</i>-Gens und</claim-text>
<claim-text>(5) ein mutiertes ETR1-Protein,</claim-text>
und</claim-text>
<claim-text>b.) einen für die Schotendehiszenzzone selektiven Promoter, der die Nukleotidsequenz gemäß SEQ<!-- EPO <DP n="63"> --> ID Nr. 13 zwischen den Positionen 1 839 und 2 328 umfaßt,</claim-text>
wobei diese Pflanze durch im Vergleich zu einer Pflanze, die dieses chimäre, für die Schotendehiszenzzone selektive Gen nicht enthält, durch Eigenschaften einer verzögerten Schotendehiszenz <b>gekennzeichnet</b> ist.</claim-text></claim>
<claim id="c-de-01-0005" num="0005">
<claim-text>Pflanze nach Anspruch 4, in der die transkribierte DNA-Region für eine Ribonuklease codiert, wobei die Pflanze außerdem ein zweites chimäres Gen, umfassend
<claim-text>a.) eine zweite transkribierte DNA-Region, die für eine RNA, ein Protein oder ein Polypeptid codiert, die bei Expression in Zellen, die nicht zu den Schotendehiszenzzonezellen zählen, der Aktivität des Genprodukts des chimären, für die Schotendehiszenzzone selektiven Gens entgegenwirkt bzw. diese verhindert oder hemmt; und</claim-text>
<claim-text>b.) einen zweiten in Pflanzen exprimierbaren Promoter, der die Expression der zweiten transkribierten DNA-Region zumindest in diesen Zellen, die nicht zu den Schotendehiszenzzonezellen zählen, steuert,</claim-text>
in ihr Genom integriert umfaßt, wobei Expression des zweiten chimären Gens die Auswirkungen der schwachen Expression des chimären, für die Schotendehiszenzzone selektiven Gens in den Zellen, die nicht zu den Schotendehiszenzzonezellen zählen, verhindert oder hemmt.</claim-text></claim>
<claim id="c-de-01-0006" num="0006">
<claim-text>Pflanze nach Anspruch 5, wobei die transkribierte Region des chimären, für die Schotendehiszenzzone<!-- EPO <DP n="64"> --> selektiven Gens für Barnase codiert und wobei die zweite transkribierte Region für Barstar codiert.</claim-text></claim>
<claim id="c-de-01-0007" num="0007">
<claim-text>Pflanze nach Anspruch 5 oder 6, wobei es sich bei dem in Pflanzen exprimierbaren Promoter, der die Expression der zweiten transkribierten DNA-Region steuert, um einen Nopalinsynthasepromoter oder einen CaMV35S-Minimalpromoter handelt.</claim-text></claim>
<claim id="c-de-01-0008" num="0008">
<claim-text>Pflanze nach einem der Ansprüche 1 bis 7, bei der es sich um eine <i>Brassica-</i>Art handelt.</claim-text></claim>
<claim id="c-de-01-0009" num="0009">
<claim-text>Pflanze nach einem der Ansprüche 1 bis 3, in der es sich bei dem in Pflanzen exprimierbaren Promoter um einen für die Schotendehiszenzzone selektiven Promoter handelt.</claim-text></claim>
<claim id="c-de-01-0010" num="0010">
<claim-text>Pflanze nach Anspruch 9, in der der für die Schotendehiszenzzone selektive Promoter die Nukleotidsequenz gemäß SEQ ID Nr. 13 zwischen den Positionen 1 839 und 2 328 umfaßt.</claim-text></claim>
<claim id="c-de-01-0011" num="0011">
<claim-text>Pflanze nach einem der Ansprüche 4 bis 10, in der der für die Schotendehiszenzzone selektive Promoter ein Fragment mit einer Länge von ungefähr 661 Nukleotiden stromaufwärts von dem Nukleotid in Position 2 329 gemäß SEQ ID Nr. 13 umfaßt.</claim-text></claim>
<claim id="c-de-01-0012" num="0012">
<claim-text>Pflanze nach einem der Ansprüche 4 bis 11, in der der für die Schotendehiszenzzone selektive Promoter die Nukleotidsequenz gemäß SEQ ID Nr. 13, die zwischen Position 251 und 1 052 beginnt und bei Position 2 328 endet, umfaßt.</claim-text></claim>
<claim id="c-de-01-0013" num="0013">
<claim-text>Pflanze nach einem der Ansprüche 4 bis 12, in der der für die Schotendehiszenzzone selektive Promoter die Nukleotidsequenz gemäß SEQ ID Nr. 13 zwischen den Positionen 1 und 2 328 umfaßt.<!-- EPO <DP n="65"> --></claim-text></claim>
<claim id="c-de-01-0014" num="0014">
<claim-text>Pflanze nach einem der Ansprüche 4 bis 13, in der der für die Schotendehiszenzzone selektive Promoter eine 5'-nichttranslatierte Leitsequenz eines anderen in Pflanzen exprimierbaren Gens umfaßt.</claim-text></claim>
<claim id="c-de-01-0015" num="0015">
<claim-text>DNA, die die Nukleotidsequenz gemäß SEQ ID Nr. 13 zwischen den Positionen 1 839 und 2 328 umfaßt.</claim-text></claim>
<claim id="c-de-01-0016" num="0016">
<claim-text>DNA nach Anspruch 15, die ein ungefähr 661 Nukleotide langes Fragment stromaufwärts vom Nukleotid in Position 2 329 gemäß SEQ ID Nr. 13 umfaßt.</claim-text></claim>
<claim id="c-de-01-0017" num="0017">
<claim-text>DNA nach Anspruch 15 oder 16, die die Nukleotidsequenz gemäß SEQ ID Nr. 13, die zwischen Position 251 und 1 052 beginnt und bei Position 2 328 endet, umfaßt.</claim-text></claim>
<claim id="c-de-01-0018" num="0018">
<claim-text>DNA nach einem der Ansprüche 15 bis 17, die die Nukleotidsequenz gemäß SEQ ID Nr. 13 zwischen den Positionen 1 und 2 328 umfaßt.</claim-text></claim>
<claim id="c-de-01-0019" num="0019">
<claim-text>Für die Schotendehiszenzzone selektiver Promoter, der die DNA nach einem der Ansprüche 15 bis 18 umfaßt.</claim-text></claim>
<claim id="c-de-01-0020" num="0020">
<claim-text>Für die Schotendehiszenzzone selektiver Promoter nach Anspruch 19, der die 5'-nichttranslatierte Leitsequenz eines anderen in Pflanzen exprimierbaren Gens umfaßt.</claim-text></claim>
<claim id="c-de-01-0021" num="0021">
<claim-text>Chimäres, für die Schotendehiszenzzone selektives Gen gemäß einem der Ansprüche 1-14.</claim-text></claim>
<claim id="c-de-01-0022" num="0022">
<claim-text>Pflanzenzelle oder Pflanzenzellkultur, die mit dem chimären, für die Schotendehiszenzzone selektiven Gen nach Anspruch 21 transformiert ist.<!-- EPO <DP n="66"> --></claim-text></claim>
<claim id="c-de-01-0023" num="0023">
<claim-text>Samen einer Pflanze, die das chimäre, für die Schotendehiszenzzone selektive Gen nach Anspruch 21 enthält, wobei dieser Samen das chimäre, für die Schotendehiszenzzone selektive Gen umfaßt.</claim-text></claim>
<claim id="c-de-01-0024" num="0024">
<claim-text>Verfahren zur Herstellung einer Pflanze mit den Eigenschaften einer verzögerten Schotendehiszenz, umfassend folgende Schritte:
<claim-text>a.) Transformieren des Zellkerngenoms einer Zelle einer Pflanze mit dem chimären, für die Schotendehiszenzzone selektiven Gen nach Anspruch 21; und</claim-text>
<claim-text>b.) Regenerieren einer transformierten Pflanze aus der transformierten Zelle.</claim-text></claim-text></claim>
</claims><!-- EPO <DP n="67"> -->
<claims id="claims03" lang="fr">
<claim id="c-fr-01-0001" num="0001">
<claim-text>Plante comprenant un gène chimère sélectif d'une zone de déhiscence d'une gousse incorporé dans le génome nucléaire de ses cellules, dans laquelle ledit gène chimère sélectif d'une zone de déhiscence d'une gousse comprend les fragments d'ADN suivants liés fonctionnellement :
<claim-text>a) une région d'ADN transcrite codant pour un ARN capable d'inhiber ou de réduire l'expression d'un gène végétal endogène codant pour une hydrolase de la paroi cellulaire, exprimée de manière sélective dans des cellules de la zone de déhiscence d'une gousse, ladite hydrolase de la paroi cellulaire comprenant la séquence d'acides aminés de la protéine codée par la séquence nucléotidique SEQ ID N° 1, entre le nucléotide à la position 95 et le nucléotide à la position 1393 ; et</claim-text>
<claim-text>b) un promoteur pouvant être exprimé dans une plante, qui oriente l'expression de ladite région d'ADN transcrite au moins dans lesdites cellules de ladite zone de déhiscence d'une gousse,</claim-text>
dans laquelle ladite plante est <b>caractérisée par</b> des propriétés retardées de la déhiscence d'une gousse lorsqu'elle est comparée avec une plante ne contenant pas ledit gène chimère sélectif d'une zone de déhiscence d'une gousse.</claim-text></claim>
<claim id="c-fr-01-0002" num="0002">
<claim-text>Plante selon la revendication 1, dans laquelle ladite région d'ADN transcrite code pour un ARN<!-- EPO <DP n="68"> --> antisens, qui est orienté vers un ARN sens dudit gène végétal endogène.</claim-text></claim>
<claim id="c-fr-01-0003" num="0003">
<claim-text>Plante selon la revendication 1, dans laquelle ladite région d'ADN transcrite code pour un ribozyme, qui est orienté vers un ARN sens dudit gène végétal endogène.</claim-text></claim>
<claim id="c-fr-01-0004" num="0004">
<claim-text>Plante comprenant un gène chimère sélectif d'une zone de déhiscence d'une gousse incorporé dans le génome nucléaire de ses cellules, dans laquelle ledit gène chimère sélectif d'une zone de déhiscence d'une gousse comprend les fragments d'ADN suivants liés fonctionnellement :
<claim-text>a) une région d'ADN transcrite codant pour une protéine ou un polypeptide qui, lorsqu'elle est produite dans lesdites cellules de la zone de déhiscence d'une gousse, les tue ou les inactive ou bien interfère avec leur métabolisme, physiologie ou développement normal, et est choisie dans le groupe composé de :
<claim-text>(1) une ribonucléase,</claim-text>
<claim-text>(2) une cytotoxine,</claim-text>
<claim-text>(3) une tryptophane monooxygénase, une indole-3 acétamide hydrolase, une amidohydrolase,</claim-text>
<claim-text>(4) le produit du gène <i>rolB</i> et</claim-text>
<claim-text>(5) une protéine ETR1 mutante ;</claim-text>
et</claim-text>
<claim-text>b) un promoteur sélectif d'une zone de déhiscence d'une gousse comprenant la séquence nucléotidique de la SEQ ID N° 13, entre les positions 1.839 et 2.328,</claim-text>
dans laquelle ladite plante est <b>caractérisée par</b> des propriétés retardées de la déhiscence d'une gousse lorsqu'elle est comparée avec une plante ne contenant pas ledit gène chimère sélectif d'une zone de déhiscence d'une gousse.</claim-text></claim>
<claim id="c-fr-01-0005" num="0005">
<claim-text>Plante selon la revendication 4, dans laquelle ladite région d'ADN transcrite code pour une ribonucléase, ladite plante comprenant en outre un<!-- EPO <DP n="69"> --> deuxième gène chimère intégré dans son génome, comprenant :
<claim-text>a) une deuxième région d'ADN transcrite, codant pour un ARN, une protéine ou un polypeptide, qui, lorsqu'elle est exprimée dans des cellules n'étant pas d'une zone de déhiscence d'une gousse, neutralise, empêche ou inhibe l'activité du produit génique dudit gène chimère sélectif d'une zone de déhiscence d'une gousse ; et</claim-text>
<claim-text>b) un deuxième promoteur pouvant être exprimé dans une plante, qui oriente l'expression de ladite deuxième région d'ADN transcrite au moins dans lesdites cellules n'étant pas d'une zone de déhiscence d'une gousse,</claim-text>
dans laquelle l'expression dudit deuxième gène chimère empêche ou inhibe les effets d'une expression basse dudit gène chimère sélectif d'une zone de déhiscence d'une gousse dans lesdites cellules n'étant pas d'une zone de déhiscence d'une gousse.</claim-text></claim>
<claim id="c-fr-01-0006" num="0006">
<claim-text>Plante selon la revendication 5, dans laquelle ladite région transcrite, provenant dudit gène chimère sélectif d'une zone de déhiscence d'une gousse, code pour un barnase et dans laquelle ladite deuxième région transcrite code pour un barstar.</claim-text></claim>
<claim id="c-fr-01-0007" num="0007">
<claim-text>Plante selon la revendication 5 ou la revendication 6, dans laquelle ledit promoteur pouvant être exprimé dans une plante, qui oriente l'expression de ladite deuxième région d'ADN transcrite, est un promoteur de nopaline synthase ou un promoteur minimum de CaMV35S.</claim-text></claim>
<claim id="c-fr-01-0008" num="0008">
<claim-text>Plante, selon l'une quelconque des revendications 1 à 7, qui est une espèce <i>Brassica.</i></claim-text></claim>
<claim id="c-fr-01-0009" num="0009">
<claim-text>Plante selon l'une quelconque des revendications 1 à 3, dans laquelle ledit promoteur<!-- EPO <DP n="70"> --> pouvant être exprimé dans une plante est un promoteur sélectif d'une zone de déhiscence d'une gousse.</claim-text></claim>
<claim id="c-fr-01-0010" num="0010">
<claim-text>Plante selon la revendication 9, dans laquelle ledit promoteur sélectif d'une zone de déhiscence d'une gousse comprend la séquence nucléotidique de la SEQ ID N° 13, entre les positions 1.839 et 2.328.</claim-text></claim>
<claim id="c-fr-01-0011" num="0011">
<claim-text>Plante selon l'une quelconque des revendications 4 à 10, dans laquelle ledit promoteur sélectif d'une zone de déhiscence d'une gousse comprend un fragment de 661 nucléotides environ en amont du nucléotide à la position 2.329 de la SEQ ID N° 13.</claim-text></claim>
<claim id="c-fr-01-0012" num="0012">
<claim-text>Plante selon l'une quelconque des revendications 4 à 11, dans laquelle ledit promoteur sélectif d'une zone de déhiscence d'une gousse comprend la séquence nucléotidique de la SEQ ID N° 13, débutant entre les positions 251 et 1.052 et finissant à la position 2.328.</claim-text></claim>
<claim id="c-fr-01-0013" num="0013">
<claim-text>Plante selon l'une quelconque des revendications 4 à 12, dans laquelle ledit promoteur sélectif d'une zone de déhiscence d'une gousse comprend la séquence nucléotidique de la SEQ ID N° 13, entre les positions 1 et 2.328.</claim-text></claim>
<claim id="c-fr-01-0014" num="0014">
<claim-text>Plante selon l'une quelconque des revendications 4 à 13, dans laquelle ledit promoteur sélectif d'une zone de déhiscence d'une gousse comprend une séquence de tête en 5', non traduite, d'un autre gène pouvant être exprimé dans une plante.</claim-text></claim>
<claim id="c-fr-01-0015" num="0015">
<claim-text>ADN comprenant la séquence nucléotidique de la SEQ ID N° 13, entre les positions 1.839 et 2.328.<!-- EPO <DP n="71"> --></claim-text></claim>
<claim id="c-fr-01-0016" num="0016">
<claim-text>ADN, selon la revendication 15, comprenant un fragment de 661 nucléotides environ en amont du nucléotide à la position 2.329 de la SEQ ID N° 13.</claim-text></claim>
<claim id="c-fr-01-0017" num="0017">
<claim-text>ADN, selon la revendication 15 ou 16, qui comprend la séquence nucléotidique de la SEQ ID N° 13, débutant entre les positions 251 et 1.052 et finissant à la position 2.328.</claim-text></claim>
<claim id="c-fr-01-0018" num="0018">
<claim-text>ADN, selon l'une quelconque des revendications 15 à 17, qui comprend la séquence nucléotidique de la SEQ ID N° 13, entre les positions 1 et 2.328.</claim-text></claim>
<claim id="c-fr-01-0019" num="0019">
<claim-text>Promoteur sélectif d'une zone de déhiscence d'une gousse comprenant l'ADN selon l'une quelconque des revendications 15 à 18.</claim-text></claim>
<claim id="c-fr-01-0020" num="0020">
<claim-text>Promoteur sélectif d'une zone de déhiscence d'une gousse, selon la revendication 19, comprenant la séquence de tête en 5', non traduite, d'un autre gène pouvant être exprimé dans une plante.</claim-text></claim>
<claim id="c-fr-01-0021" num="0021">
<claim-text>Gène chimère sélectif d'une zone de déhiscence d'une gousse tel qu'il est défini selon l'une quelconque des revendications 1 à 14.</claim-text></claim>
<claim id="c-fr-01-0022" num="0022">
<claim-text>Cellule végétale ou culture de cellules végétales transformée avec le gène chimère sélectif d'une zone de déhiscence d'une gousse selon la revendication 21.</claim-text></claim>
<claim id="c-fr-01-0023" num="0023">
<claim-text>Graine d'une plante contenant le gène chimère sélectif d'une zone de déhiscence d'une gousse, selon la revendication 21, ladite graine comprenant ledit gène chimère sélectif d'une zone de déhiscence d'une gousse.<!-- EPO <DP n="72"> --></claim-text></claim>
<claim id="c-fr-01-0024" num="0024">
<claim-text>Procédé de production d'une plante ayant des propriétés retardées de la déhiscence d'une gousse, qui comprend les étapes consistant à :
<claim-text>a) transformer le génome nucléaire d'une cellule de plante avec le gène chimère sélectif d'une zone de déhiscence d'une gousse, selon la revendication 21 ; et</claim-text>
<claim-text>b) régénérer une plante transformée à partir de ladite cellule transformée.</claim-text></claim-text></claim>
</claims>
</ep-patent-document>
